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ABSTRACT
A Study of Epithelial Cl- Secretion in the Murine Distal Colon
Trey S. Rottgen
Colonic epithelium has an on-going basal level of Cl- secretion, which is
necessary for maintaining a properly hydrated epithelial mucus layer, and the
movement of waste products. However, alterations in the level of Cl- secretion
can have significant effects. Loss of colonic Cl- secretion, such as that seen in
Cystic Fibrosis or ulcerative colitis can result in intestinal obstruction. While
infection with Vibrio cholera or increased activity of the Enteric nervous system
(ENS) can result in increased Cl- secretion and resultant diarrhea. In this study,
we decided to evaluate both sides of the spectrum via an animal model of
inflammatory bowel disease, and study ENS regulation of epithelial Cl- secretion.
Ulcerative colitis (UC) is well-characterized to have a significant
attenuation in colonic Cl- secretion. An animal model of UC, which utilizes the
epithelial irritant dextran-sulfate sodium (DSS), has also been shown to have
significantly blunted epithelial Cl- secretion. More specifically, previous
observations have demonstrated the loss of Ca2+-activated Cl- secretion.
Therefore in our study, we examined Ca2+-activated Cl- secretion in murine distal
colon mounted in Ussing chamber. A subset of animals underwent a chronic
induction model of DSS-colitis. Animals that received DSS demonstrated a loss
of Ca2+-activated Cl- secretion when stimulated with carbochol in Ussing chamber
experiments. Protein isolated from colonic epithelium of DSS-colitis animals
demonstrated a significant decrease in the Ca2+-activated Cl- channel,
TMEM16A. This would indicate that loss of TMEM16A in colonic epithelium
following DSS-treatment contributes to the observed loss of Ca2+-activated Clsecretion in functional studies.
ENS activity has previously been observed to contribute to the measured
Cl secretion in colonic epithelium. Therefore, we decided to evaluate the efficacy
of KCNQ K+ channel activators to hyperpolarize and decrease enteric neuronal
signaling. Flupirtine, a pan-KCNQ activator, was able to significantly inhibit ongoing Cl- secretion measured as a function of short-circuit current (ISC) in Ussing
chamber preparations. Application of tetrodotoxin (TTX), following flupirtine, was
unable to inhibit Cl- secretion, however reversal of order of application resulted in
a significant inhibition of Cl- secretion via TTX. Immunofluorescence studies also
demonstrated the co-localization of KCNQ2 and KCNQ3 with axons of enteric
neurons positively-labeled with choline acetyltransferase. From these results, we
conclude that activation of KCNQ2 and KCNQ3 in enteric neurons is able to
inhibit basal Cl- secretion in colonic epithelium.
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Chapter I

INTRODUCTION

1

The function of the large intestine (colon) is primarily to absorb water from
the lumen, participate in electrolyte homeostasis, and propel waste forward for
elimination in the form of feces.
For the average adult, the colon absorbs approximately 1.5-2 liters of
water each day [1]. This can increase to as much as 5-6 liters of water absorption
in the circumstance of increased volume presentation [2]. However, volumes
exceeding this limit or presentation of a large bulk volume will result in diarrhea.
Water absorption is heavily reliant on electrolyte transport in the colon, as
evidenced by several pathologies that lead to excess luminal electrolytes and
resultant water loss [3]. However, the relative contribution of the paracellular
versus transcellular pathways is still under investigation [4].
Electrolyte transport within the colon is accomplished via movement
through a paracellular and transcellular pathway [1]. Paracellular movement
makes up the largest component, however as contents progress distally within
the colon, the transcellular component increases [1]. The paracellular component
is simply movement of electrolytes down a concentration gradient, but the
transcellular movement is performed via a myriad of transporters and ion
channels that line the colonic mucosa. Together, the two pathways are able to
absorb approximately 100 mmol/L of Na+ each day, with an astounding upper
limit of 400 mmol/L per day [5].
Elimination of waste following water and electrolyte absorption is driven by
a complex series of coordinated muscle contractions that propel the feces
forward for elimination via defecation. The muscle contractions are not under
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conscious control or even under the control of the central nervous system for the
most part. This is primarily accomplished by a nervous system of the
gastrointestinal tract known as the enteric nervous system [6].
These separate, but incredibly intermingled tasks are accomplished via an
interaction between the absorptive surface or epithelium of the colonic mucosa
and the enteric nervous system. The following chapter will provide greater detail
on both the epithelial layer and enteric nervous system, as well as elaborate on
an ion channels specific to each.

Colonic Epithelium
The epithelial layer lining the colonic lumen consists of a simple columnar
epithelium intermixed with mucus-secreting goblet cells [7]. The organization of
epithelium at the level of the cell consists of an apical membrane that is exposed
to luminal contents, and a basolateral membrane that interacts directly with the
interstitial space. This kind of organization gives the epithelial cells a type of
“polarity” upon differentiation that is simply the localization of different
transporters [7]. Epithelial cells are anchored to a basement membrane and other
epithelial cells via tight junction proteins [8]. The purpose of a “tight” epithelial
layer is to minimize interaction between the “outside” and the host’s immune
system [9]. Histological examination of the colonic epithelium reveals a repeating
pattern of crypts of Lieberkuhn followed by surface cells [7]. The historical
paradigm characterizes these different locations as secretory cells located within
the crypts and absorptive cells localized at the surface of the mucosa [10, 11].
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Whether this is actually the case is debatable, however this provides an avenue
to discuss some general electrolyte transport within the colon.
The primary cation that is absorbed in the colon is the monovalent Na+ ion
[12]. In the proximal portions and to a lesser degree in distal portions of the
colon, Na+ is absorbed via the electroneutral transporter sodium/hydrogen
exchanger isoform 3 (NHE3) [13]. NHE3 is coupled to the down-regulated in
adenoma (DRA) transporter that exchanges Cl- and HCO3- [14, 15]. This
mechanism is coupled via pH changes within the cellular microenvironment that
absorbs a single Na+ coupled with absorption of a single Cl-, while extruding a
proton and single HCO3- molecule [14]. Upon moving to a more distal location
within the colon, Na+ absorption changes from handling via NHE3 to the
electrogenic, epithelial Na+ channel (ENaC) [16, 17]. The movement of Na+
through ENaC is mediated by a favorable electrochemical gradient that is
generated via Na+/K+ atpase, which is located on the basolateral membrane [7].
The “pump” moves intracellular Na+ to the interstitial space and creates a void by
which extracellular Na+ located on the apical side of the membrane can move
down its electrochemical gradient [18]. Also, the movement of Na+ into the cell
and eventual basolateral extrusion via the Na+/K+ pump causes absorption of
water (H2O) via paracellular movement or aquaporin proteins located within
apical membranes of colonic epithelium [19, 20].
While Na+ absorption is a major component of on-going electrolyte
transport within the colon, the presence of an electrogenic anion secretion is
present [21]. In Ussing chamber studies, the majority of observed short-circuit
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current (ISC) can be attributed to apical anion secretion. The primary component
of this basal anion secretion is comprised of the Cystic Fibrosis transmembrane
regulator (CFTR) [22, 23]. The channel is so named due to its association with
the disease Cystic Fibrosis. It was characterized to mediate the observed
pathology in the early 1990s [24, 25]. The channel is a cAMP-sensitive Clchannel that has a single-channel conductance of only 8-12 pS [26, 27].
However, stimulation with basolateral forskolin (FSK) can induce observable
currrents in either whole-cell patch clamp electrophysiology or Ussing chamber.
At the time of identification of the CFTR channel or lack thereof in CF patients,
many researchers observed the presence of a compensatory Cl- current [28, 29].
This additional Cl- current seemed to be activated more through Ca2+-sensitive
pathways instead of intracellular production of cyclic nucleotides [28-30].
The Ca2+-activated Cl- channel (CaCC) was initially observed in Xenopus
oocytes [31]. The channel demonstrated a slight voltage and time-dependence
upon activation at lower Ca2+ concentrations. Also, the channel was sensitive to
inhibition by niflumic acid with an apparent Ki of 17 µM [31]. Several potential
CaCCs have been proposed; however practically all putative candidates did not
demonstrate a similar electrophysiological profile to the CaCC initially described
in Xenopus oocytes [32-34]. More recently though, three separate groups
identified a CaCC that resembles the native current in electrophysiological terms
[35-37]. Since the identification of this new putative CaCC, it has been named
TMEM16A. The initial studies on TMEM16A demonstrated the channel to be
localized to salivary and cultured human bronchial epithelial cells [35, 36].
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Following these initial observations, another group utilizing a global knock-out
mouse of TMEM16A demonstrated an absence of a Ca2+-activated Cl- current in
mouse trachea [38].
Similar to the reports of TMEM16A-mediating the Ca2+-activated Cl- current in
native respiratory epithelium, the mice were also used to study colonic epithelium
[38, 39]. Transepithelial potential [VTE] of distal colon administered basolateral
carbachol

(CCH;

cholinergic

agonist

that

increases

intracellular

Ca2+

concentration) was able to significantly hyperpolarize in Tmem16a+/+ mice [38].
However, Tmem16a-/- littermates were not able to respond to basolateral CCH
administration [38]. Calculated ISC from control animals was approximately 60
µA/cm2, while Tmem16a-/- animals had a calculated ISC of about 10 µA/cm2 [38].
It was not until recently that the tissue-specific [Vil1] knock-out mice of TMEM16A
confirmed the previously observed results [40]. Similar to the global knockout
mice, CCH-stimulated ISC was significantly less in the Tmem16a-/- animals [40].
TMEM16A has been observed in several human colonic epithelial cell lines.
The HT-29 and T84 cell lines have both demonstrated expression of TMEM16A,
characterized by immunoblot [41, 42]. However, a group that employed the use
of siRNA targeted against TMEM16A in the T84 cell line did not demonstrate a
large decrease in ATP-stimulated ISC [43]. The only change in the measured ISC
was the initial peak prior to the plateau phase of the trace, which would
potentially indicate a minor role for TMEM16A in human colonic epithelium [43].
However, ATP-stimulated ISC in T84 cells has previously been characterized to be
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mediated more through adenosine receptors, instead of Ca2+-increasing
purinergic receptors [44].

Characterization of the Ca2+-activated Cl- Channel TMEM16A
Considerable research has also focused on the physical characterization of
TMEM16A [45-47]. One of the initial findings suggested that the final quaternary
structure of TMEM16A existed as a dimer in the plasma membrane [48]. This
was demonstrated with TMEM16A proteins that were fused to either GFP or
mCherry [48]. The different TMEM16A conjugates were able to undergo
fluorescence resonance energy transfer [FRET], which indicated a close
proximity of the two proteins [48]. However, it was not until a couple of years later
that the actual sequence of amino acids important for this interaction was
identified [49]. Mutants of TMEM16A lacking an α-helix that corresponded to
residues 161-179 were not able to form functional channels, hence the lack of
observed Cl- currents in transfected HEK 293 cells [49].
Shortly after this discovery, a group was able to identify several residues that
were important for the voltage-dependence of the channel, as well as amino
acids that participate in the Ca2+-sensitivity of TMEM16A [50]. The residues that
confer a voltage-dependence of the channel were found to be located within the
first intracellular loop and consisted of four repeating glutamic acid residues
[444EEEE] [Fig. 1] [50]. Alanine substitution at these residues shifted the halfmaximal activation of the channel from 64 ± 0.9 mV to a more depolarized
potential of ≈160 mV at 1 µM Ca2+ [50]. Also, the residues important for Ca2+-
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sensitivity were found to be located directly adjacent to the glutamic acid
residues and consisted of a glutamic acid, alanine, valine, and lysine [448EAVK]
[Fig. 1] [50]. Deletion of these particular residues was able to shift the Ca2+sensitivity drastically from 1 µM (which was able to increase open-probability at
very hyperpolarized potentials) to 25 µM Ca2+ (which could increase openprobability only marginally) [50]. While EAVK residues are undoubtedly important
for channel gating, it has also been shown that glutamic acid residues [E702/705]
are also essential for Ca2+-sensitivity of TMEM16A [Fig. 1] [51]. This was
demonstrated by mutants of these two residues having a Ca2+-sensitivity several
orders of magnitude less than their respective wild-type [WT] channel [[Ca2+], 20
µM WT vs. 2 mM E702/705 M] [51]. The importance of these residues was
confirmed by another group that mutated these same amino acids and obtained
a channel with significantly less Ca2+-sensitivity [52]. This group was able to
demonstrate cooperativity between these residues and the amino acids initially
found to confer sensitivity [448EAVK] [52]. Three other acidic moieties [E650,
E730, D734] have been shown to contribute to the Ca2+-sensitivity of TMEM16A
[51]. Also, Scudieri et al. developed TMEM16A chimera proteins by substituting
residues from TMEM16B [another member of the protein family, also exhibiting
Ca2+-stimulated Cl- secretion] into the sequence of TMEM16A to determine
potential domains necessary for Ca2+-binding [53].

The group was able to

determine from their results that the third intracellular loop of TMEM16A
participates in conferring Ca2+-sensitivity to the channel [53]. This was made
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obvious by the deletion of these residues resulting in a shift of the EC50 of Ca2+
from 0.25 µM to 2 µM at a holding potential of +100 mV [53].
While the previously mentioned work was essential for identifying residues
necessary for Ca2+-binding and voltage-sensitivity [50, 51, 53], it was not until the
crystal structure was elucidated that researchers could more clearly visualize the
interaction of the previously mentioned residues [and several others] in Ca2+binding and channel gating of TMEM16A [54]. In 2014, Brunner et al. were the
first group to generate a crystal structure of TMEM16 from Nectria haematococca
[nhTMEM16] [54]. The conserved protein from Nectria haematococca only
functions as a lipid scramblase, however, the protein is still sensitive to Ca2+ and
demonstrates increased scramblase activity with increasing concentrations of
Ca2+ [54]. The results of the study were able to demonstrate that nhTMEM16
does in fact associate as a dimer in the plasma membrane [54]. This study also
described a Ca2+-binding segment that was embedded within the hydrophobic
membrane [54]. This research group was also the first one to postulate the
possible mechanisms of ion conductance by either a single pore or doublebarreled architecture [46, 54]. Following the initial observations obtained from the
crystal structure of nhTMEM16, two different groups were able to resolve the
crystal structure of TMEM16A from murine origin [47, 55, 56]. This new
information about the channel was able to illuminate important residues for
interaction with conducting anions as well as illustrate that each monomer of
TMEM16A was able to bind two individual Ca2+ ions [55]. Also, the greater
resolution with the murine TMEM16A allowed for an accurate description of how
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Ca2+-binding mediates Cl- conductance [56]. This is accomplished via a hinge
mechanism that is dependent on a glutamic acid residue [E654] interacting with
two Ca2+ ions that allow for opening of a single pore within the channel [56].
As evidenced by the tremendous amount of research that has been
conducted on the characterization of TMEM16A there is still much to be done in
the future. Hopefully, the previous observations can be utilized to further
characterize the channel in regard to potential protein-protein interactions, or the
development of novel antagonists that allow for the pharmacological study of the
channel in isolation. Also, some preliminary evidence indicates a potential role for
the channel in several pathologies. Whatever the case, research will continue on
the CaCC, TMEM16A.
Enteric Nervous System
The enteric nervous system (ENS) in humans contains about as many
neurons as the entire spinal cord, which is approximately 500 million neurons
[57]. Due to the ENS containing so many neurons, it has previously been referred
to as the “mini-brain of the gut”. Almost every neurotransmitter that has been
identified in the central nervous system (CNS) has also been observed in the
ENS [58]. The complexity of the ENS is so vast that the majority of the
gastrointestinal tract can function with local control from ENS neurons, instead of
extrinsic signals from the CNS [59, 60]. The ENS has the ability to regulate local
blood flow in the tissue, motility of the tract, and electrolyte secretion via control
of epithelial tissue [61]. The ENS is primarily localized to two major layers: the
submucosal plexus and the myenteric plexus [6]. The submucosal plexus is
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located just beneath the submucosa, while the myenteric plexus is actually
located between the two smooth muscle layers of the GI tract (circular and
longitudinal).
Whether located within the myenteric or submucosal plexus, there is a
wide variety of neurons that contribute to the proper functioning of the
gastrointestinal tract, however, they can be generally subdivided into afferent and
efferent limbs of the ENS. Intrinsic primary afferent neurons (IPANs) have axons
that sample the luminal contents for noxious stimuli that could cause harm to the
mucosal layer, as well as, exhibiting an ability to respond to inflammatory
mediators [62-64]. Integration of these signals can lead to a reflexive arc utilizing
other ENS neurons or the stimulation of a centrally-mediated arc to increase
motility and secretion to dilute and eliminate any potential hazard [61]. While the
IPANs are sensory in function, the ENS is not without effector neurons such as
secretomotor neurons [6]. Axons originating from the secretomotor neurons can
stretch either in an ascending or descending longitudinal fashion as to coordinate
an overall complex response of rhythmic muscle contractions [6, 65]. Some of
these axons may even project to the mucosa to synapse on epithelium [66]. With
this type of patterned distribution, the secretomotor neurons are able to
increase/decrease contraction of the smooth muscle of the GI tract and in turn
increase or decrease motility, as well as, signal to the epithelial layer to modify
on-going electrolyte transport depending on the current synaptic inputs [6, 66].
As far as signaling within the ENS, many different neurotransmitters are
utilized regardless of whether the neuron is a secretomotor neuron or IPAN [58].

11

However,

cholinergic

fibers

(acetylcholine-releasing,

ACh)

comprise

approximately 60% of the total fibers within the ENS [67]. In many cases, ACh is
released along with small neuropeptides such as vasoactive intestinal peptide or
calcitonin-gene related peptide, which contribute to the overall observed
response [58]. ACh that is released from secretomotor neurons mediates its
effect through muscarinic receptors located on smooth muscle or the basolateral
surface of the epithelium. The binding of ACh to a muscarinic receptor leads to a
transient increase in intracellular Ca2+, which may mediate a contraction of
smooth muscle or an increase in Cl- secretion from epithelium, depending on the
localization of release [68, 69].
While the released neurotransmitter is the actual molecule that can
modulate the activity of its target, it is universally understood that ion channels
located on a neuron can regulate the release of said neurotransmitter [70, 71].
Previous studies have shown that blockade of voltage-sensitive Na+ channels
(NaV) with tetrodotoxin (TTX) can prevent release of neurotransmitter via
inhibition of the propagating action potentials [72]. Neurotransmitter release can
also be inhibited in this same fashion from enteric neurons [73, 74]. However, the
generation of an action potential and eventual release of a neurotransmitter is
dependent on the cell reaching a threshold potential.
Hyperpolarization via activation of K+ channels in neurons can prevent
synaptic inputs from reaching a threshold potential. More specifically though,
activation of KCNQ (KV7) channels or the “M” current in CNS neurons is able to
cause a significant hyperpolarization and inhibition of neurotransmitter release
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[75]. A previous group has also shown that activation of KV7 channels on
neuronal cell membranes of the ENS can cause a dramatic hyperpolarization and
prevent IPANs from responding to the noxious stimulus bradykinin [76]. The
group was also able to show that distension with supraphysiological pressures
was unable to generate an action potential when neurons were hyperpolarized
via activation of KCNQ channels.
Characterization of KCNQ Channels
KCNQ channels are voltage-sensitive K+ channels (KV) [77, 78]. All
members of the family consist of six transmembrane domains [79, 80]. The fourth
of which is the S4 domain and confers the voltage-sensitivity to the KCNQ family,
as well as, all voltage-sensitive K+ channels [81-83]. The group is composed of
five different isoforms, which are simply KCNQ1-KCNQ5 [77, 84-86]. Similar to
many other K+ channels [87-89], the KCNQ family associates in the membrane
as a tetramer to form the functional channel [90, 91]. These channels have been
characterized as slowly deactivating with visible currents at hyperpolarized
potentials [92]. The family of channels are also frequently referred to as the “M”
current. This is due to early observations that stimulating the M1 receptor would
inhibit the visible current [93, 94]. However, stimulation of receptors for
angiotensin II, bradykinin, or purines will cause inhibition of the current or really
any other Gαq activation pathway [95-97]. The KCNQ family has also been
characterized as contributing to resting membrane potential in many different cell
types [98-101]. The channels have been functionally identified and have been
shown to play a major role in a vast array of tissues, including vestibular hair
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cells of the inner ear, cortical neurons, cardiac repolarization, and K+ recycling in
respiratory and colonic epithelium [102-106]. Several pathologies, which include
a form of deafness, a familial type of epilepsy, as well as the long QT syndrome
in the heart have been linked to mutations in one variant or another [102, 107,
108]. The aforementioned diseases also demonstrate the functional importance
of KCNQ channels in cellular membranes.
While several different isoforms of the KCNQ family exist, only a couple
have real functional significance in neuronal tissue. KCNQ2 (KV7.2) and KCNQ3
(KV7.3) are the primary contributors to the M current in neuronal tissue, however,
in some peripheral circuits KCNQ5 (KV7.5) has been identified [101, 109, 110].
Early observations of the neuronal M current demonstrated that the current, as
previously mentioned, could be inhibited via activation of muscarinic receptors
[94]. The mechanism of inhibition would later be shown to be PIP2 depletion in
the cellular membrane [111]. It was also shown that the native M current could
dampen the excitability of neurons and therefore reduce the amount of action
potentials [112, 113].
In 1998, Biervert et al. was able to clone the open-reading frame of one of
these channels, KCNQ2 [114]. The study was able to show that not only was this
in fact a voltage-sensitive K+ channel, but mutations in the channel were directly
linked to a neonatal seizure disorder through the cloning of a mutant isoform from
a patient [114]. In that same year, Wang et al. was able to not only clone KCNQ2
independently, but also clone KCNQ3 [77]. In vitro transcribed cRNA of KCNQ2
and KCNQ3 was injected into Xenopus oocytes and voltage-clamped for
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functional characterization [77]. KCNQ2, as previously described, had observable
currents, however, injection of KCNQ3 alone did not produce currents above that
of background [77]. Co-expression of the two isoforms increased the observed
currents dramatically. Also, the co-expression of the two channels seemed to
affect sensitivity to the inhibitor tetraethylammonium (TEA), since the previous Kd
for KCNQ2 alone was much less than during co-expression of both channels
(0.16 ± 0.02 mM vs. 3.5 ± 0.7 mM) [77]. More importantly though, the study was
able to show that co-expression of the two channels resulted in a profile that was
similar to the native M current in half-activation (-45.4 mV vs. -46.7 mV, M vs.
KCNQ2/3) and pharmacological inhibition to XE-991 (0.98 ± 0.15 µM vs. 0.6 ±
0.1 µM, M vs. KCNQ2/3) [77]. This was a major discovery in identifying the
putative neuronal M current channels.
Animal models utilizing genetic manipulations have been very useful in
determining the importance of KCNQ2 and KCNQ3 in neuronal physiology. In
2005, a group utilized a dominant-negative knock-in of KCNQ2 [112]. M currents
were significantly less than wild-type littermates. Also, spike-frequency was
significantly increased in neurons expressing the KCNQ2 dominant-negative.
Unfortunately, a genetic deletion model of KCNQ2 resulted in death of peri-natal
mice within only a few hours of birth [115]. Less has been done with KCNQ3,
however, one group did develop a model utilizing a substitution of glycine to
valine at position 311 [116]. This specific mutation is derived from a family that
was well characterized to have benign familial neonatal convulsions. Animals
homozygous for this mutation demonstrated a significant attrition rate as
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compared to heterozygotes. Elicited current upon a step protocol demonstrated a
significantly blunted response to depolarizing potentials.
Following some of these observations that clearly indicated KCNQ2/3
were important to overall neuronal excitability, it was shown that the channels
associated with ankyrin-G in axon initial segments (AIS) [117, 118]. This
interaction was shown to be mediated via several c-terminal residues.
Substitution of those residues in KCNQ2 (E810A, S811A, D812A) and KCNQ3
(E837A, T838A, D839A) (Fig. 2) resulted in loss of localization to the AIS in
cultured hippocampal neurons [118]. Shah et al. developed a small peptide that
was able to disrupt this interaction in brain slices undergoing patch clamp
electrophysiology [119]. Application of the ankyrin-binding-peptide (ABP) did
result in an overall depolarization of hippocampal neurons. More interestingly
though, the disruption in the AIS led to a dramatic reduction (7.8 ± 0.8 mV) in the
threshold potential for generation of an action potential [119].
Another residue that may have less importance for channel localization
but definitely has significance in terms of modulation of channel activity is the
residue important for binding of several pharmaceuticals such as retigabine and
flupirtine. Both have been shown to be potent activators of native M current, as
well as expressed KCNQ2 and KCNQ2/3 subunits [120, 121]. The substitution of
a single tryptophan (W236 Q2/ W265 Q3) (Fig. 2) can result in complete loss of
sensitivity to retigabine [122, 123]. The proposed mechanism is that binding to
the tryptophan can stabilize the activation gate, which would increase activation,
as well as, slow deactivation of the channel (Both phenomenon have been
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observed in electrophysiology experiments) [123]. Flupirtine has not been
scrutinized in this same way. However, the drug shares substantial homology to
retigabine and is assumed to promote channel activation in a similar manner.
Inflammatory bowel Disease
This group of diseases are characterized as inflammation along the
gastrointestinal tract (GI), primarily occurring in the distal portions of the small
intestine and all throughout the colon [124]. Inflammatory bowel disease (IBD) is
primarily two different diseases, which are Crohn’s disease and ulcerative colitis.
Crohn’s disease while normally localized to the small and large bowel can
potentially manifest in any portion of the GI tract. Also, Crohn’s disease can elicit
inflammation throughout the entire thickness of the bowel, ranging from the
epithelial layer to the underlying longitudinal smooth muscle [125]. This can result
in the formation of strictures or even bowel perforations. However, ulcerative
colitis (UC) is only localized to the large bowel. It is clinically characterized as
inflammation beginning within the rectum and moving proximally. In severe cases
of pancolitis (inflammation of the entire colon), “inflammatory backwash” can
move into the distal ileum of the small bowel causing inflammation. As far as
inflammation within the tissue, UC is typically isolated to the mucosa (epithelium)
and submucosa [126]. Besides differences in the location of the two diseases,
the two pathologies also have a different profile when it comes to the
inflammatory response. Crohn’s Disease typically has a cytokine profile that
resembles a Th1 response, while UC is more typically a Th2 response [125, 126].
While this information has provided avenues for the development of new
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therapies, the actual etiology of either disease is still unknown and under intense
research.
Since tissue from a patient can only be obtained upon manifestation of the
disease, many animal models have been utilized to more fully understand the
pathogenesis of IBD [127]. One of the more common models utilized for IBD
research is the dextran-sulfate sodium (DSS)-induced colitis model [128-130].
The model has been shown to have consistent results as well as offering ease of
replication. Animals that undergo DSS exposure are simply administered their
normal drinking water supplemented with 2-5% DSS [128]. The size of the
dextran has been shown to impact the severity of colitis that develops within
animal. The typical size that is utilized within the literature is 36,000-50,000
daltons [131, 132]. The overall histopathological features that develop are similar
to IBD with a large inflammatory infiltrate in the laminia propria, crypt distortion,
and crypt abscesses [133]. However, selection of the host has been shown to
impact the elicited inflammatory response. C57Bl/6 mice when exposed to DSS
typically develop Th1-type response (Crohn’s disease), but Balb/c mice when
administered DSS develop more of a Th2 inflammatory response, which is more
similar to the clinical pathology of UC [126, 134, 135].
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Specific Aims:

Specific Aim 1: To determine if the observed absence of Ca2+-activated Clsecretion in DSS-colitis is the result of the down-regulation of the Ca2+-activated
Cl- channel, TMEM16A. To evaluate this, functional evidence will be collected
utilizing the Ussing chamber to measure epithelial Cl- secretion from mounted
colonic epithelium from either control or DSS-colitis mice. Also, protein
expression/localization of TMEM16A will also be evaluated using immunoblot
and immunohistochemistry techniques.

Specific Aim 2: To determine if activation of KCNQ channels in enteric neurons
can inhibit apical Cl- secretion via hyperpolarization and resultant inhibition of
neurotransmitter release. Mounted colonic epithelium from murine distal colon
will have flupirtine (KCNQ activator) applied to the basolateral membrane in the
presence or absence of other inhibitors of the ENS. Also, co-localization via
immunofluorescence of KCNQ2 and KCNQ3 with choline acetyl transferase will
be carried out to determine the presence of and potential contributors to the
observed effect in functional studies.
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Figure 1. Schematic of TMEM16A channel protein with identified residues
necessary for voltage and Ca2+-sensitivity. TMEM16A channel protein
consists of 10 transmembrane domains [TMD]. The intracellular loop
between TMD-2 and TMD-3 contains the voltage-sensitive 444EEEE residues,
as well as, the

448EAVK

residues that participate in Ca2+-sensitivity of the

channel. The E702 and E705 residues located within the seventh TMD also
participate in Ca2+-sensitivity of the channel. The third intracellular loop
(shown in pink), and the residues E654, E730 and D734 have also been
implicated to affect Ca2+-sensitivity of the channel.
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Figure 2. Schematic of KCNQ2 and KCNQ3 channels with labeled residues
important for drug binding and channel localization. Tryptophan (W 236 Q2/ W
265 Q3) labeled in yellow is necessary for binding of retigabine and the
homologous drug, flupirtine. The orange box correlates to residues important for
localization to axon initial segments (AIS). Deletion or substitution of these
residues results in a complete loss of localization. The S4 domain is important
voltage-sensitivity of the channel (hence labeling with the positive signs).
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Abstract. Attenuated Ca2+-activated Cl- secretion has previously been observed
in the model of dextran-sulfate-sodium (DSS)-induced colitis. Prior studies have
implicated dysfunctional muscarinic signaling from basolateral membranes as the
potential perpetrator leading to decreased Ca2+-activated Cl- secretion. However,
in our chronic model of DSS-colitis, Chrm3 transcript (1.028 ± 0.12 vs. 1.029 ±
0.27, p > 0.05) and CHRM3 protein expression (1.021 ± .24 vs. .928 ± .09, p >
0.05) were unchanged. Therefore, we hypothesized that decreased CCHstimulated Cl- secretion in DSS-induced colitis can be attributed to a loss of Ca2+activated Cl- channels (CaCC) in apical membranes of colonic epithelium. To
establish chemically-induced colitis, Balb/C mice were exposed to 4% DSS for 5
alternating weeks to stimulate a more moderate, chronic colitis. Upon completion
of the protocol, whole thickness sections of colon were mounted in the Ussing
chamber under voltage-clamp conditions. DSS-induced colitis demonstrated a
complete inhibition of basolateral administration of CCH-stimulated Cl- secretion
that actually displayed a reversal in polarity (15.40 ± 2.22 µA/cm2 vs. -2.47±0.25
µA/cm2). Western blot of potential CaCCs, quantified by densitometric analysis,
demonstrated no change in bestrophin-2 (BEST2) and cystic fibrosis
transmembrane regulator (CFTR), while Anoctamin-1 (ANO1, TMEM16A) was
significantly down-regulated (1.001 ± 0.13 vs. 0.510 ± 0.12, p < 0.05). Our
findings indicate that decreased expression of TMEM16A in DSS-induced colitis
contributes to the decreased Ca2+-activated Cl- secretion in murine colon.
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Introduction
Chloride secretion in secretory epithelium has been primarily subdivided
into cAMP-stimulated and Ca2+-activated through the use of different
pharmacological agonists (9, 13). Aberrations in Cl- secretion have been
observed in several pathological conditions, which include Cystic Fibrosis, Vibrio
cholera infection, and inflammatory bowel disease (8, 14, 37). Decreased Clsecretion in ulcerative colitis (UC) or animal models of UC (dextran-sulfate
sodium; DSS) has been previously reported (10, 12). More specifically, Ca2+activated Cl- secretion has been shown to be decreased in the DSS-induced
colitis animal model (3, 16, 19). Previous studies focused on this phenomenon
concluded the attenuation to be attributable to dysfunctional muscarinic signaling
from the basolateral surface of colonic epithelium (1, 18). However more
recently, it has been reported to be possible perturbations in ion channel
function/expression in colonic epithelium (16).
Ca2+-activated Cl- channels (CaCCs) have been implicated to be involved
in epithelial differentiation, salivary secretion and mucociliary clearance (28, 30,
35). However initial attempts to characterize CaCCs proved difficult, as potential
candidates did not match the biophysical properties of the native protein (15). In
the past decade a novel CaCC, anoctamin 1 (ANO1, TMEM16A), was identified
by three separate groups (6, 34, 40). Young et al demonstrated that injected
siRNA to Tmem16a significantly inhibited pilocarpine (muscarinic agonist)stimulated salivary secretion in mice (40), while Caputo et al was able to achieve
a similar knockdown of Ca2+-activated Cl- secretion with siRNA targeted to
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TMEM16A in primary human bronchial epithelial cells (6). Following these
seminal discoveries, several groups utilizing a global gene knock-out of
Tmem16a demonstrated the absence of Ca2+-activated Cl- secretion in secretory
epithelium isolated from trachea and colon (28, 30). However, the global deletion
of the gene resulted in tracheal malacia and premature death of the animal (29).
More recently, a tissue-specific knock-out of Tmem16a was developed. Isolated
distal colon from these mice demonstrated an absence of Ca2+-activated Clsecretion following CCH administration (4).
While TMEM16A has been identified as the primary mediator of Ca2+activated Cl- secretion in colonic epithelium, it has not been studied in DSSinduced colitis. Thus, the goal of this study was to identify as to whether the
previously described decreased Ca2+-activated Cl- secretion in colonic epithelium
was attributable to decreased expression of TMEM16A in a DSS-induced chronic
colitis. Our results indicate that TMEM16A protein expression is down-regulated
in a chronic model of DSS-induced colitis and contributes to the observed loss in
Ca2+-activated Cl- secretion.
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Materials and Methods
Animals. Non-fasting male Balb/cAnNCrl mice (17 weeks old, Charles River,
NY) were provided normal chow for the entirety of the project. Prior to the
beginning of the 10-week project, mice (7 weeks) were randomly selected for
either control or DSS groups, respectively. Balb/C mice selected for the DSS
protocol were provided 4% DSS for 5 days (with 9 days of normal drinking water
in between) for 5 alternating weeks, beginning with the first week. Animals
utilized for the acute protocol were assigned to either control or DSS groups.
DSS groups were administered 4.5% DSS in the drinking water for five (5)
consecutive days followed by one day of normal drinking water. Both groups
were then euthanized on the seventh day of the protocol. All animals used in the
study were provided food and water ad libitum. All animals were anesthetized
with intraperitoneal (i.p.) injection of Fatal Plus (Patterson Veterinary, SC). The
experimental protocols used in this study were approved by the West Virginia
University Institutional Animal Care and Use Committee.
Histology and Immunohistochemistry. Distal colon segments were isolated
from euthanized mice via bilateral pneumothorax. Isolated colonic segments
were measured immediately upon removal with a constant temperature of 2223oC. Distal colon segments were then rinsed with phosphate-buffered saline
(PBS) to remove any residual content and debris. Colonic segments were then
opened longitudinally along the mesenteric border. An approximate 3 mm piece
of segment was then cut from the intact colon and immediately placed in 10%
neutral-buffered formalin for tissue fixation. Fixed tissue was then given to the
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West Virginia University Translational Pathology Department for paraffinembedding and haemotoxylin and eosin (H&E) staining. Prepared slides
consisted of 5 µm thick sections mounted on glass slides, followed by H&E
staining for visualization of tissue architecture from the respective treatment
groups. Immunohistochemistry was also performed on control and DSS tissue by
the West Virginia University Translational Pathology Department to determine the
localization of TMEM16A in whole thickness sections of mouse distal colon. AntiTMEM16A antibody (Alomone, Jerusalem, Israel) was used at a dilution of 1:100.
Sectioned tissue was incubated at 37oC for a period of one hour in primary
antibody. Following the initial step, tissue was incubated in goat anti-rabbit
horseradish-peroxidase conjugated secondary antibody (1:1000) for one hour.
Finally, a chromogenic substrate was added for visualization of immune-stained
slides. All images were captured with the AxioImager (Carl Zeiss, Germany) on a
20x magnification.
Electrophysiology. Distal Colons were removed from euthanized mice via
bilateral pneumothorax and rinsed with ice-cold PBS to clear residual contents.
Segments were opened longitudinally along the mesenteric border to expose the
epithelium. Full thickness tissue was then mounted on a pin slider with an oval
aperture of 2.8 w x 11 l mm with a cross-sectional area of 0.30 cm2 and placed in
the EasyMount Ussing chamber (Physiological Instruments, San Diego, CA) for
electrophysiological study as previously described (26). Mounted tissue was
bathed on both sides with Ringers’ solution (in mM: 115 NaCl, 25 NaHCO3, 2.4
K2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 1.2 MgCl2 and 10 glucose), while also being
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continuously voltage-clamped at 0 mV to abolish any developing electrochemical
gradient. ISC was continuously monitored with a 5 mV pulse applied to the tissue
every 5 s to measure resistance (Ω). Transepithelial voltages (VTE) were
calculated using Ohm’s law.
ΔV = (ΔISC * RTE)
Tissues were continuously maintained at 37oC and gassed with 5% CO2-95% O2
(pH:7.4). Mounted tissue was incubated for 30 minutes with 5 µM indomethacin
and 1 µM tetrodotoxin to inhibit prostaglandin synthesis and potentially activated
enteric neurons, respectively. Following equilibration, 10 µM amiloride was added
apically to inhibit minor electrogenic Na+ absorption (ENaC) in the distal colon.
Upon reaching a steady-state, tissue was administered 100 µM carbachol (CCH)
basolaterally to activate Gαq muscarinic receptors to indirectly activate apical
Ca2+-activated Cl- secretion via intracellular increases in Ca2+ (11, 22). Fifteen
minutes following CCH addition, 10 µM forskolin (FSK, adenylate cyclase
inhibitor that increases intracellular cAMP) was basolaterally added to assess
tissue viability. All representative traces and presented group data are
designated as positive deflections indicating apical anion secretion/cation
absorption or negative deflections representative of cation secretion/anion
absorption.

Colonic Epithelial Cell Isolation. Distal colons were isolated from euthanized
mice via bilateral pneumothorax and immediately rinsed with ice-cold phosphatebuffered saline (PBS) to clear luminal contents. The distal colon was then
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opened longitudinally along the mesenteric border. Tissue was then cut into
approximately 2 mm long pieces and submerged in 40 mL of ice-cold PBS with 5
mM EDTA in a 50 mL Falcon tube. The pieces of tissue in PBS-EDTA were then
incubated at 37oC with gentle rocking for 30 minutes. Following this incubation,
colonic tissue was vigorously shaken to disperse colonic crypts and surface
epithelium in solution. Supernatant was then loaded into 1.5 mL microcentrifuge
tubes and spun at 1x103 g for 5 minutes to pellet suspended cells. Isolated
epithelial cells were used in downstream applications, such as RT-qPCR and
Immunoblotting.

RNA Isolation and RT-qPCR analyses. Isolated colonic epithelium were
resuspended in Qiazol (Qiagen, Valencia, Ca). Total-RNA was isolated using the
MicroRNEasy kit, as per manufacturer’s instructions (Qiagen, Valencia, Ca).
Concentrated RNA was immediately quantified using the Nanodrop 1000
(Thermo, Waltham, MA). RNA was then stored at -80oC until further application.
Real-time PCR was carried out using a one-step kit that included 10 minutes of
reverse transcription of total-RNA (50 ng/well) followed immediately by
quantitative PCR utilizing a dsDNA-binding dye (New England Biolabs, Ipswich,
MA). Custom primers (400 nM/primer/well) designed using the NCBI primerblast application were utilized to amplify specific targets (Table-1). Determination
of differential expression was achieved using the 2-

ΔΔ

Ct

method, (21). β-Actin

threshold cycles for each sample were obtained and then subtracted from
threshold cycles of transcripts of interest to obtain a ΔCt value. The ΔCt value
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from control samples was then subtracted from DSS-colitis samples to obtain a
ΔΔCt value. Fold changes of transcripts of interest were then calculated as 2-

ΔΔ

Ct

.This method was utilized for comparison of all quantitative PCR values
presented within the text and figures.

Protein Isolation and Western Blotting.

Pelleted colonic epithelium were

resuspended in 350 µl of RIPA (radioimunnoprecipitation assay) buffer containing
full protease inhibitor cocktail (cOmplete, Mini, Sigma-Aldrich, St. Louis, MO).
Tissue was homogenized using glass homogenizers with a final sonication step
to fully liberate transmembrane proteins. Protein concentration for each individual
sample was determined using the Pierce BCA protein quantification kit (Thermo,
Waltham, MA). Samples were then immediately frozen at -80oC and maintained
there until further use. On the day of immunoblotting, protein samples were
removed from the -80oC freezer and allowed to thaw on ice. Samples were
diluted to 1 µg/µl with the addition of 4x Lammelli buffer (Biorad, Hercules, CA)
and remaining volume with diH2O. Following preparation, protein samples were
warmed at 37oC in a water bath for 15 minutes and then loaded at 20 µg/well
onto handcast tris-glycine gels (SureCast, Invitrogen, Waltham, MA). Running
conditions consisted of 85V until passing the stacking buffer at which point the
gel was completed at 135V. Gels were transferred to PVDF membranes for 90
minutes at a constant 20V. Upon completion, PVDF membranes were blocked in
5% non-fat dry milk (Kroger, Cincinnati, OH) in tris-buffered saline with 0.1%
tween-20 (TBST) for a period of 1 hour at room temperature. PVDF membranes
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were then incubated in primary antibody: TMEM16A 1:500, CFTR 1:200, BEST2
1:500, M3R 1:200 (Alomone Labs, Jerusalem, Israel), IP3R 1:500, β-Actin
1:1000 (Cell Signaling, Danvers, MA) overnight at 4oC. In the morning,
membranes were washed 5x in TBST for 5 minutes and then placed in goat antirabbit horseradish-peroxidase conjugated secondary antibody (1:10000 dilution)
for 2 hours at RT. Membranes were washed 5x in TBST and imaged on the GBox (Syngene, Cambridge, United Kingdom). All target proteins were quantified
using the imageJ software (National Institute of Health, Bethesda, MD) with
normalization to β-Actin.
Statistics. All presented results represent mean ± standard error (SE) from five
different animals, unless otherwise denoted. Statistical tests that were performed
on the presented data sets were either unpaired student’s t-test or one-way
ANOVA with Tukey post-hoc analysis using GraphPad Prism 6.0 (San Diego,
CA). p < 0.05 was used for determination of significance.

Stock Solutions. DSS (MP Biomedicals, Burlington, MA) 4% in the drinking
water. Ussing chamber stock solutions were: 5 mM Indomethacin (Indo,
dissolved in ethanol; Sigma-Aldrich, St. Louis, MO), 1 mM Tetrodotoxin (TTX,
dissolved in acetic acid; Tocris Pharmaceuticals, Minneapolis, MN), 10 mM
Amiloride (Amil, dissolved in DMSO; Sigma-Aldrich, St. Louis, MO), 100 mM
Carbochol (CCH, dissolved in deionized water; Sigma-Aldrich, St. Louis, MO), 10
mM Forskolin (FSK, dissolved in DMSO; Tocris Pharmaceuticals, Minneapolis,
MN), and 3 µM Ionomycin (IONO, dissolved in DMSO; Tocris Pharmaceuticals,
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Minneapolis, MN). All stock solutions were diluted 1:1000 in the chamber to
obtain [µM].
Results
Induction of Chronic DSS-colitis in Balb/c mice. Model accuracy was
evaluated using several parameters previously utilized to demonstrate consistent
induction of DSS-colitis (19). Colon length in the DSS-colitis group exhibited a
consistent shortening as compared to control mice (Fig. 1A). Group data of
measured colonic lengths from control mice were significantly longer than their
DSS counterparts (8.75 ± 0.276 cm vs. 6.05 ± 0.221 cm, p < 0.001) (Fig. 1B).
Histological studies were also conducted to examine proper colitis induction. The
whole thickness of tissue isolated from control mice exhibited normal histological
architecture (i.e. stacked test tubes) with intact surface epithelium and minimal
inflammatory cells located in the lamina propria (Fig. 1C, top). Colonic mucosa
from DSS-colitis animals exhibited substantial widening of the lamina propria as
a result of an influx of inflammatory cells (Fig. 1C, bottom). Crypts in the colitic
colon were also distorted with an obvious enlargement of the underlying
muscularis (Fig. 1C, bottom), which could be the result of increased proliferation.
However, this could also be the result of colonic contraction and without a marker
for proliferation cannot be excluded. Transcript abundance of acute-phase
reactants was quantitated to further demonstrate active inflammation within the
distal colon. Quantitative PCR (qPCR) demonstrated a significant increase in
cytokine transcript abundance of TNFα (1.008 ± 0.033 vs. 8.293 ± 0.732, p <
0.0001) and IL-6 (0.980 ± 0.017 vs. 10.530 ± 1.045, p < 0.0001) from DSS-colitis
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samples (Fig. 1D). Besides the prototypical inflammatory cytokines, Th2mediated cytokines were selected for study for their relevance to the clinical
pathology, UC. IL-17 mRNA abundance was not significantly increased (1.000 ±
0.754 vs. 2.964 ± 0.676), however, transcript abundance of IL-4 (1.506 ± 0.747
vs. 7.109 ± 2.229, p < 0.05), IL-10 (1.062 ± 0.144 vs. 11.310 ± 2.262, p < 0.01),
and IL-33 (0.998 ± 0.028 vs. 4.340 ± 1.367, p < 0.05) were all significantly
increased in the DSS-colitis mice (Fig. 1D).
Effect of Chronic DSS-induced Colitis on Ca2+-activated Cl- Secretion.
Control mucosa demonstrated a robust increase in Ca2+-activated Cl- secretion,
which was measured as positive deflections in short-circuit current (ISC) (ΔISC,
15.40 ± 2.22 µA/cm2, n = 5) (Fig. 2F). This was paralleled by a calculated
hyperpolarization of transepithelial potential (ΔVTE, -1.64 ± 0.21 mV, n=5) (Fig.
2E) following 100 µM CCH application (Fig. 2A/C). DSS-treated mucosa did elicit
a response upon application of CCH, however, this response was significantly
smaller in magnitude and opposite in apparent charge (Fig. 2B/D). The decrease
in measured ISC (ΔISC, -2.47 ± 0.25 µA/cm2, n=5) (Fig. 2F) most likely indicates
activation of Ca2+-activated K+ channels, which are known to reside in the apical
membrane of colonic epithelium (31, 32, 36, 42). This altered response to
basolateral CCH could potentially be related to decreased synthesis of
prostaglandin E2, which has previously been shown to uncouple CCHadministration from apical Cl- secretion (7). Also, calculated VTE paralleled this
response with a slight depolarization due to increased positive charge
accumulating on the luminal side of the chamber (ΔVTE, 0.296 ± 0.07 mV, n = 5)
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(Fig. 2E). Application of basolateral 10 µM Forskolin (FSK) was administered to
assess the tissues ability to respond to another physiological agonist (Fig. 2C/D).

Effect of Acute DSS-induced Colitis on Ca2+-activated Cl- Secretion.
Following our initial observations in the Ussing chamber that recapitulated
previously published work with the acute model of DSS, along with western blot
quantification of TMEM16A that demonstrated a decrease in expression (1.000 ±
0.13 vs. 0.065 ± 0.01, p < 0.05), we decided to utilize the acute model (16, 19).
This was done to establish that changes in CCH-induced ISC were in fact due to
aberrations in intracellular Ca2+ responses. However, we first needed to establish
that our acute model of DSS-induced colitis was in agreement with previously
published literature (16). As previously seen with our controls from the chronic
model, control mucosa elicited a robust increase in ISC (ΔISC, 29.42 ± 6.42
µA/cm2, n = 6) when exposed to basolateral 100 µM CCH (Fig. 3A/C). Also as
expected, colonic mucosa isolated from animals that received DSS demonstrated
a drop in baseline ISC (ΔISC, -2.43 ± 0.17 µA/cm2, n = 6) following basolateral 100
µM CCH (Fig. 3B/C). To then establish that Ca2+ mediates the CCH-induced
changes in ISC in control and DSS mucosa, 3 µM ionomycin (calcium ionophore,
IONO) was added prior to basolateral CCH administration. 3 µM IONO induced
an increase in measured ISC in control mucosa (ΔISC, 15.30 ± 2.24 µA/cm2, n = 4)
(Fig. 3D/E), which was followed by basolateral addition of 100 µM CCH.
Administration of CCH was only able to minimally increase ISC (ΔISC, 0.90 ± 1.09
µA/cm2, n = 4) (Fig. 3D/E). And when compared to mucosa that was treated with
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CCH prior to IONO, the measured increase in ISC was significantly less (ΔISC,
29.42 ± 6.42 µA/cm2 vs. 0.90 ± 1.09 µA/cm2, p< 0.01) (Fig. 3F). Colonic mucosa
from DSS-colitis mice was then incubated with 3 µM IONO, which caused a drop
in baseline ISC (ΔISC, -3.21 ± 0.73 µA/cm2, n = 4) (Fig. 3G/H). Following this, 100
µM CCH was administered to the basolateral surface of the tissue. CCH was only
able to elicit a small drop in measured ISC (ΔISC, -0.31 ± 0.49 µA/cm2, n = 4) (Fig.
3G/H). Overall, this demonstrated a similar pattern to control mucosa of CCHinduced ISC being attenuated when following IONO administration (ΔISC, -3.21 ±
0.73 µA/cm2 vs.

-0.31 ± 0.49 µA/cm2, p< 0.01) (Fig. 3I). Taken together, these

results would indicate that CCH-induced changes ISC are Ca2+-mediated in both
control and DSS-exposed mucosa.

Effect of Chronic DSS-induced Colitis on Cl- Channel Transcript
Abundance. RT-qPCR analysis was utilized to assess transcript abundance of
several Cl- channels known to be expressed in distal colonic epithelium (28, 37,
41). Two Ca2+-activated Cl- channels (Tmem16a, Best2) as well as the cystic
fibrosis transmembrane regulator (Cftr) were selected for analysis. Tmem16a
mRNA abundance was significantly decreased in epithelium isolated from DSScolitis mice (1.045 ± 0.15 vs 0.325 ± 0.04, p < 0.01) (Fig. 4A), which may indicate
a potential decrease in translated channel protein. However, Best2 (0.993 ± 0.03
vs. 0.301 ± 0.32, p < 0.001) and Cftr (1.042 ± 0.209 vs. 0.096 ± 0.013, p < 0.01)
were also significantly decreased as compared to control animals (Fig. 4B/C).
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Effect of Chronic DSS-induced Colitis on Cl- Channel Protein Expression in
Mucosal Lysates. Western blot of epithelial lysates focused on different Clchannels implicated to elicit a response to increasing intracellular levels of Ca2+
in colonic epithelium. Western blot technique was carried out on lysates to
assess potential differences in protein expression between control and DSS
mice. As previously seen with the RT-qPCR data, TMEM16A was significantly
down-regulated in DSS-colitis (1.001 ± 0.13 vs. 0.510 ± 0.12, p < 0.05) (Fig.
5A/B). However, western blot quantification of BEST2, another CaCC, from the
lysates demonstrated no difference between control and DSS groups (0.952
±0.04 vs. 0.930 ± 0.031, p > 0.05) (Fig. 5A/C). CFTR was also quantified via
western blot technique. This was to address previous observations that have
described a mechanism by which CFTR is Ca2+-sensitive (5, 38). Protein
expression for CFTR was also unaltered (1.074 ± 0.09 vs. 1.053 ± 0.07, p > 0.05)
(Fig. 5A/D) despite the mRNA transcript abundance being significantly
decreased, similar to Best2 (Fig. 4B/C).
Transcript and Protein Abundance of Gαq Muscarinic Signaling Pathway.
Previous work has shown that the decreased CCH-stimulated ISC in DSS-colitis
was attributable to aberrations in signaling of pro-secretory stimuli (1, 18). To
assess this from the standpoint of activation by CCH, mRNA abundance, as well
as protein expression, of the M3 receptor (CHRM3), a prototypical Gαq G-protein
coupled receptor, was quantified in the distal colon. mRNA transcript abundance
for Chrm3 was unchanged between control and DSS-colitis groups (1.028 ± 0.12
vs. 1.029 ± 0.27, p > 0.05) (Fig. 6A). Western blot quantification of CHRM3 was
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also unchanged between the different experimental groups (1.021 ± 0.24 vs.
0.928 ± 0.09, p > 0.05) (Fig. 6B/C). While signal transduction is initiated through
CHRM3, canonical Gαq signaling also includes the production of the second
messenger inositol triphosphate (IP3), which leads to the release of Ca2+ via
binding to the inositol triphosphate receptor (ITPR3). While Itpr3 transcript
abundance was not significantly decreased (0.988 ± 0.09 vs. 0.816 ± 0.05, p >
0.05), protein expression of ITPR3 was significantly down-regulated (1.000 ±
0.09 vs. 0.426 ± 0.13, p < 0.01) in DSS-colitis mice as compared to their parallel
controls (Fig. 6A, B, D).
Immunohistochemistry of TMEM16A in Distal Colon of Control and DSS
Mice. Immunohistochemistry (IHC) of TMEM16A was performed to follow-up the
finding of decreased protein expression with immunoblotting (Fig. 5A/B) and to
determine the exact localization of that protein. IHC performed with antiTMEM16A antibody on control tissue demonstrated staining of the surface
epithelium with additional staining of the upper crypts (Fig. 7A). However, DSSexposed tissue that was incubated with anti-TMEM16A antibody demonstrated
substantially less membrane staining of the epithelium, with more generalized
staining of the cytoplasm (Fig. 7C). This generalized staining, especially in DSScolitis, is most likely sub-apical vesicles that have not been properly trafficked to
the plasma membrane, however, the staining could also be potential splice
variants of TMEM16A located in cellular organelles. Control peptide experiments
incubated with the anti-TMEM16A antibody were run in parallel for both groups.
The addition of peptide to either Control or DSS-colitis tissue was devoid of
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staining indicating specificity of the antibody, instead of possible non-specific
binding to similar epitopes (Fig. 7B/D).

Discussion
Utilizing the previously described model of colitis in mice (20, 39), five
alternating weeks of 4% DSS administration was able to induce epithelial
dysplasia, crypt distortion and increased inflammatory infiltrate in the lamina
propria, similar to the histopathological features observed in UC (2). Previously,
acute induction of DSS-colitis had resulted in decreased CCH-stimulated Ca2+activated Cl- secretion in murine distal colon (3, 16). However, these losses in
Ca2+-activated Cl- secretion have been attributed to dysfunctional muscarinic
receptor signaling (1), or membrane depolarization related to decreased
functioning of basolateral K+ channels (16). These previous works were also
conducted prior to the discovery of the novel CaCC, TMEM16A (6, 34, 40).
TMEM16A exhibits a similar electrophysiological profile to that found in cultured
and native human bronchial epithelium (6). Also, global and tissue-specific
knockout studies of TMEM16A in mice have demonstrated an absence of Ca2+activated Cl- secretion (4, 28).
In this study, our findings demonstrate a significant attenuation in Ca2+activated Cl- secretion in the colitic colon that is in part due to the downregulation of TMEM16A. This conclusion is evidenced by the use of a Ca2+
ionophore (ionomycin) that demonstrates a complete lack of Ca2+-activated Clsecretion (Fig. 3), as well as significantly decreased mRNA abundance and
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protein expression of TMEM16A in the DSS-induced colitic colon (Figs. 4 & 5). In
addition, other potential canonical and non-canonical CaCCs were also
examined (5, 41). Transcript abundance was decreased for both Best2 and Cftr
(Fig. 4), however, the protein expression of these Cl- channels in whole cell
lysates was unchanged in the colitic colon, as compared to control littermates
(Fig. 5). Also, transcript abundance and protein expression of CHRM3 were
unchanged in DSS-induced colitis (Fig. 6), which is in agreement with a more
recent publication (16). Taken together, our results indicate that decreased
expression of TMEM16A following DSS administration substantially blunts Ca2+activated Cl- secretion in murine distal colon.
While TMEM16A expression was substantially down-regulated, the protein
expression of ITPR3 was also significantly decreased in the DSS-colitis cohort
(Fig. 6). And while this could contribute to the attenuation in CCH-stimulated Clsecretion in DSS-colitis, a previous observation with a tissue-specific knockout of
TMEM16A in colonic epithelium demonstrated decreased CCH-stimulated Ca2+
release as measured by fura-2 (33). Schreiber et al. did put forth one possibility
that TMEM16A may provide a physical tether for ITPR3 to the plasma membrane
and loss of TMEM16A could disrupt this architecture (33). Also, a prior study has
demonstrated a physical interaction of TMEM16A and ITPR3 in nociceptive
neurons (17). Taken together with our findings, the diminished expression of
TMEM16A in colonic epithelium could cause a destabilization of ITPR3 in
endoplasmic reticular membranes, leading to a premature degradation of the
receptor. This notion is supported by the fact that mRNA abundance of Itpr3
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(0.988 ± 0.09 vs. 0.816 ± 0.05, p > 0.05) is not significantly decreased in DSScolitis (Fig. 6). This would potentially indicate a non-genomic mechanism of
decreased protein expression, possibly a protein-protein interaction between
ITPR3 and TMEM16A.
Though it is most likely that the down-regulation of TMEM16A is a result of
transcriptional regulation, it is uncertain as to what mechanism mediates this
regulation of the channel. Several groups have previously shown that IL-4 and IL13, Th2 immune mediators, were able to significantly increase Ca2+-activated Clsecretion in bronchial epithelium (6, 43). Another group incubated IL-4 and IL-13
on immortalized colonic epithelium (T84), and while IL-13 did not seem to have an
effect, IL-4 was able to substantially inhibit the CCH-stimulated ISC in a dosedependent manner (23). Another study incubated IL-10 on T84 monolayers and
was able to demonstrate a similar dose-dependent inhibition of CCH-stimulated
ISC (24). Together, this would provide support that Th2 signaling in colonic
epithelium may oppose the effects that are observed in respiratory epithelium.
Also, it is worth noting that our results demonstrate a significant increase in
transcript abundance of several prototypical Th2 cytokines (Fig. 1D), which could
lead to the decreased expression of TMEM16A.
Previous studies have demonstrated the importance for TMEM16A in
mucociliary clearance in murine airways (28, 30). Furthermore, poor hydration of
the mucus layer between secretory epithelium and resident bacteria has been
shown to promote an environment of bacterial overgrowth, leading to an
increased interaction of non-host with host (25, 27). This potentially highlights the
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impact that TMEM16A may have on colonic inflammation in UC. Utilizing these
previous observations, we speculate that decreased TMEM16A may exacerbate
colonic inflammation via an increase in interaction between resident immune
cells and the microbiota. From a clinical perspective an increase in Ca2+-activated
Cl- secretion could decrease this interaction and help to ameliorate further
inflammation induced via this mechanism.

In conclusion, our findings demonstrate a significant decrease in Ca2+activated Cl- secretion in a DSS-induced colitic colon. The CaCC, TMEM16A, is
significantly decreased in the DSS-induced colitis cohort of mice, while other Clchannels (BEST2, CFTR) were unchanged at the protein level. The significant
decrease in ITPR3 may be the result of a loss of TMEM16A stabilization through
protein-protein interactions. Also, we speculate that the loss of TMEM16A in
colonic epithelium may contribute to the inflammatory response.
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Figure Legends
Figure 1. Evaluation of DSS-colitis in Balb/C Mice. A. Representative images
of excised colons from either control or DSS-colitis cohorts. B. Group data of
measured colons from either control or colitic mice. Represented data is means ±
SE of different groups, collected from 6 different animals in each respective
group (p < 0.001). C. Haemotoxylin and eosin staining of formalin-fixed colonic
tissue. Each image represents a different animal from their corresponding
treatment. DSS-colitis (C, Bottom) demonstrates crypt dysplasia, leukocyte
infiltration, and thickening of underlying serosa (20x, AxioImager). D. RT-qPCR
analyses of multiple cytokines involved in the development of colitis. Asterisks (*)
indicate significance of each individual cytokine transcript as compared to
control. *p < 0.0001 – compared to control; $p < 0.01 – compared to control; #p <
0.05 – compared to control.

Figure 2. Effect of DSS-colitis on transepithelial potential and Cl- secretion.
A. Representative trace of calculated transepithelial potential (VTE) in control
mice following application of 100 µM carbochol (CCH) and 10 µM Forskolin
(FSK). B. Representative trace of calculated VTE in DSS-colitis mice following
application of 100 µM CCH and 10 µM FSK. C. Representative trace of elicited
short-circuit current (ISC) in control mice following basolateral administration of
100 µM CCH and 10 µM FSK. D. Representative trace of elicited ISC in DSScolitis mice following basolateral administration of 100 µM CCH and 10 µM FSK.
E. Summarized data of calculated ΔVTE following CCH administration in either
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control (open bars) or DSS-colitis (closed bars) mice. DSS-colitis demonstrates a
complete inhibition with an actual reversal in polarity as compared to control. F.
Group data of ΔISC from both control (open bars) and DSS-colitis (closed bars)
groups following CCH-administration. DSS-colitis, in parallel to calculated ΔVTE,
demonstrates an elicited current that is in opposition to that of the control cohort.
Bar graphs of summarized data represent means ± SE of 5 different animals. *p
< 0.001 - compared to control.

Figure 3. Effect of Ionomycin on CCH-induced Changes in ISC from Control
and Acute DSS-Colitis Mice. A. Representative trace of measured short-circuit
current (ISC) following basolateral 100 µM carbochol (CCH) administration to
control mucosa. B. Representative trace of ISC from DSS-colitis mucosa following
basolateral 100 µM CCH administration. C. Group data of ΔISC following CCHadministration in control and DSS mice. D. Representative trace of ISC from
control mucosa that was stimulated with 3 µM ionomycin (IONO) and followed by
100 µM CCH. E. Group Data of ΔISC with 3 µM IONO followed by 100 µM CCH in
control mucosa. F. Group data of CCH-induced ΔISC with and without 3 µM IONO
administration. G. Representative trace of ISC from mucosa exposed to DSS
administered 3 µM IONO and 100 µM CCH. H. Group data of ΔISC from DSScolitis in response to 3 µM IONO followed by 100 µM CCH administration. I.
Group data of DSS-colitis CCH-induced ΔISC with and without 3 µM IONO
administration. All presented bar graphs are summarized data that represent the
means ± SE. *p < 0.01 – compared to control.
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Figure 4. Effect of DSS-colitis on transcript abundance of Cl- channels in
murine colon. Transcript abundance was determined for (A) Tmem16a, (B)
Best2, and (C) Cftr in control (open bar) or DSS-colitis mice (closed bar). Bar
graphs of summarized data represent means ± SE of 5 different animals
normalized to an endogenous control, Actb. *p < 0.001 - compared to their
respective control.

Figure 5. Effect of DSS-colitis on Cl- channel protein expression in murine
colon. A. Representative images of protein expression of the different
characterized Cl- channels from epithelial lysates. B. TMEM16A protein
expression normalized to β-actin for quantification of control and DSS-colitis
groups. TMEM16A expression (closed bars) is significantly decreased in DSScolitis mice as compared to control. C,D. Summarized data of western blot
quantification of BEST2 and CFTR normalized to β-actin in control and DSScolitis mice. Neither protein was significantly altered from the control cohort. Bar
graphs of summarized data represent means ± SE of 5 different animals from
each respective group. *p < 0.05-compared their respective control.

Figure 6. Characterization of Gαq muscarinic signaling pathway. A.
Transcript abundance of Chrm3 and Itpr3 from control and DSS-colitis groups.
mRNA abundance of either transcript was not significantly different from the
control cohort (P>0.05). B. Representative images of western blots for CHRM3
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and ITPR3 with corresponding loading controls for normalization. C. Summarized
data of CHRM3 protein expression normalized to β-actin. CHRM3 expression in
DSS-colitis was unaltered as compared to control counterparts. D. Group data of
ITPR3 protein expression normalized to β-actin from control and DSS-colitis.
ITPR3 expression was significantly down-regulated in DSS-colitis. Bar graphs of
summarized data represent means ± SE of 5 different animals from each
respective group. *p < 0.01-as compared to control.

Figure 7. Immunohistochemistry of TMEM16A in colonic tissue sections. A.
Immunohistochemistry of TMEM16A in control tissue demonstrates pronounced
expression and localization of the protein to surface epithelium and upper crypts
(top, left). B. DSS-colitis tissue stained for TMEM16A exhibits less staining in
epithelial cells and a more diffuse signal in the lamnia propria (Bottom, left). C,D.
Both cohorts of tissue were run in parallel with a control peptide specific for the
anti-TMEM16A antibody. Both images demonstrate a lack of staining when coincubated with control peptide. Images were captured at 20x magnification on the
AxioImager (Carl Zeiss, Germany).
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GENE ID

PRIMERS (Forward & Reverse)

(ref seq)
Tmem16a

F: TCTGTGTTTATGGCCCTCTGG

NM_178642.5

R: TGACAGCTTCCTCCTCCTCC

Best2

F: CCGCCTATCGCTTCTTACTGG

Product

MELTING

Length

TEMP

(bp)

(oC)

115

F: 59.72
R: 60.62

132

NM_001130194.1 R: GATGCACCACCAGAGTCACG
Cftr

F: ATTTCACGCTCCACAGAGGC

NM_021050.2

R: CCATTAACGGGGTTGTTTTTAAGC

Chrm3

F: CTGCCAGATATGACCAGCAATGG

NM_033269.4

R: TCACTTGGTCAGAACGCAGC

Itpr3

F: ACATTGTGTCCCTGTACGCC

NM_080553.3

R: CACTTTGAAGAGGCAATCTCGG

F: 60.60
R: 61.02

118

F: 60.67
R: 59.31

141

F: 61.61
R: 60.88

143

F: 60.32
R: 59.58

Table 1. Custom qPCR primers for determination of transcript abundance.
All primers were designed utilizing the NCBI primer-blast application with the
indicated reference sequence (ref seq).
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Chapter III

Activation of KCNQ (KV7) K+ Channels in Enteric Neurons Inhibits Chloride
Secretion in the Murine Distal Colon
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Abstract. The Enteric nervous system (ENS) regulates blood flow, motility and
electrolyte transport along the entire gastrointestinal tract. KCNQ K+ channels
have been characterized to contribute to the resting membrane potential in
visceral neurons and are also present in the ENS. In this study, we wanted to
evaluate the efficacy of KCNQ activators on the ENS from the standpoint of
anion secretion in mouse distal colon. Anion (i.e. Cl-) secretion was measured as
a function of short circuit current (Isc) in intact mouse distal colon mounted under
voltage clamp conditions in an Ussing chamber. Pharmacological approaches
were utilized to assess the effect of activation of KCNQ channels in enteric
neurons on apical Cl- secretion. Immunofluorescence studies were conducted to
identify the isoform and location specific expression of KCNQ channels.
Immunofluorescence studies indicated the presence of KV7.2 and KV7.3 channels
that co-localized with choline acetyl transferase in enteric neurons of mouse
distal colon. Flupirtine, a KCNQ activator markedly inhibited ISC (i.e. Clsecretion). However, application of flupirtine following tetrodotoxin resulted in a
significantly blunted response. A similar effect was observed when tissue was
pre-incubated with the muscarinic antagonist tolterodine. Serosal nicotine
stimulated Cl- secretion in control colon. However, tissues that were pretreated
with flupirtine prior to application of nicotine remained unresponsive to the
ganglionic agonist. Our data indicate that activation of KCNQ (KV7) channels of
enteric neurons inhibits Cl- secretion. Also, activators of KCNQ channels could
have therapeutic benefit in diarrheal pathologies associated with an overall
hyperexcitable ENS.
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Introduction
The enteric nervous system (ENS) is comprised of approximately 400-600
million neurons [1]. The ENS participates in a multitude of functions that include
regulation of motility, local control of blood flow during digestion, and influence
over electrolyte transport [2-5].
Numerous pathologies have been identified that cause a dysregulation of
one or all of the previously mentioned regulatory processes [6-8]. While
Hirschprung’s disease is the most notable of ENS pathologies, and results in an
absolute loss of enteric neurons, several diseases have been identified that elicit
an overall hyperexcitable ENS [9, 10]. For example, patients with irritable bowel
syndrome with diarrhea (IBS-D) administered alosetron demonstrated delayed
colonic transit times, indicating increased serotonergic signaling and ENS
overactivity [9]. While IBS-D is considered more of a disease of the developed
world, infections with rotavirus or vibrio cholera can also cause excitation of
enteric neurons, which could increase epithelial secretion and contribute to the
overall pathology of each of those diseases [8, 11].
K+ channels are responsible for setting the resting membrane potential in
a vast array of cells due to the large permeability of K+ as compared to other
predominant ions [12]. The KCNQ (KV7) family, which are voltage-sensitive K+
channels (KV), have been described to regulate resting membrane potential in
several different cell types [13-15]. The KV7 family has been described as small,
slow-deactivating K+ channels with a hyperpolarized threshold for half-maximal
activation [16]. A couple members of the KV7 family, KV7.2 and KV7.3, have been

80

characterized as making up the native M current, and more importantly
contributing to resting membrane potential in neurons [17-20]. Disruptions in
these genes have led to the development of seizures and hyperalgesia in rodent
models [19, 21, 22].

Previous observations have also shown KV7.3 to co-

immunolocalize with sensory afferents in the gastrointestinal tract, as well as,
participate in visceral nociception [18, 23].
While the KV7 family has been shown to be present in neurons located
within the gastrointestinal tract, it has not previously been studied from the
aspect of epithelial electrolyte transport. Therefore, the goal of this study was to
evaluate the efficacy of KV7 activators on enteric neurons and the resultant effect
on mucosal electrolyte transport. Our results indicate that KV7.2/3 activation
causes an immediate and sustained hyperpolarization of enteric neurons that
results in decreased epithelial secretory function via decreased neurotransmitter
release.
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Material and Methods
Animals. Male Balb/c mice (10-13 weeks, Charles River, NY) were provided
normal chow and water ad libitium for the entirety of the project. All animals were
anesthetized via 5% inhalational isoflurane (Patterson Veterinary, SC) for
isolation of the whole colon for downstream applications. Mice were then
euthanized via cervical dislocation. All experimental protocols utilized in this
study were approved by the West Virginia University Institutional Animal Care
and Use Committee.

Cell Culture. The colonic adenocarcinoma T84 cell line (ATCC, Manassas, VA)
was maintained and passaged in a T75 flask (Corning, Corning, NY) that was
kept at 37oC and 5% CO2- 95% O2 gas. Cells were maintained in DMEM/F12
(ThermoFisher, Waltham, MA) supplemented with 10% fetal bovine serum (FBS)
(Fisher Scientific, Hampton, NH) with 1% pencillin-streptomycin (Mediatech,
Manassas, VA). Upon passage, cells were seeded close to confluence on 1.12
cm2 transwell plates (Corning, Corning, NY) for use in Ussing chamber
monolayer studies. T84 cells maintained on the transwell plates were checked for
confluence each day. Upon reaching confluence, cells were then maintained in
monolayers for 18 days for proper development of tight junctions, as well as,
differentiation of the colonic epithelial cell line. Media was replaced every other
day with fresh culture media until utilization in Ussing chamber studies.
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Electrophysiology.
Native tissue. Whole colon was removed from the anesthetized mouse and
rinsed with ice-cold phosphate-buffered saline (PBS) to remove any residual
contents. Whole colon was then pinned near the caecum in a sylgard plate filled
with ice-cold PBS containing 5 µM indomethacin. The colon was then opened
longitudinally along the mesenteric border of the tissue. The sylgard dish was
then placed under a dissecting microscope for the isolation of distal colon
segments. Whole-mount distal colon was then placed on an oval 0.04 cm2
aperture for mounting in the EasyMount Ussing chamber (Physiological
Instruments, San Diego, CA) for electrophysiological study, as previously
described [24]. Mounted tissue was then bathed with bilateral addition of 5 mL of
Ringers’ physiological saline solution (in mM: 115 NaCl, 25 NaHCO3, 2.4
K2HPO4, 0.4 KH2PO4, 3 KCl, 1.2 CaCl2, 1.2 MgCl2 and 10 glucose) to each hemichamber. Tissues were allowed to equilibrate in open-circuit conditions for a
period of 15 minutes prior to voltage-clamping. All mounted tissues were
continuously voltage-clamped at 0 mV to abolish any developing electrical
gradient. Short-circuit current (Isc) was continuously monitored with a 5 mV pulse
applied every 5 seconds to determine transepithelial resistance. Tissues were
maintained in the chamber at 37oC and continuously gassed with 5% CO2- 95%
O2 (pH 7.4).
T84 monolayers. The day of experiments, PBS was warmed in a water bath to
37oC for washing of T84 monolayers maintained on transwell plates. Inserts of T84
cells were removed from their respective plates and gently washed with warmed
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PBS until clear. Monolayers were then mounted in the EasyMount Ussing
chamber and bathed on both sides by Ringers’ physiological saline solution.
Monolayers were voltage-clamped at 0 mV for the duration of the experiment
with a 5 mV pulse applied every 5 seconds. However, all monolayers were
allowed to equilibrate and come to a steady-state prior to the application of any
drugs.
All representative traces presented within this article are designated as positive
ISC indicating either secretion of an anion or absorption of a cation from the
mucosal surface, while negative deflections of ISC indicate cation secretion or
anion absorption from the mucosal side of the tissue.

Immunofluorescence. Whole colon was removed from euthanized mice and
rinsed with ice-cold PBS to remove any residual contents. Tissues were pinned
on a sylgard plate and opened longitudinally along the mesenteric border. Colon
was then pinned along the borders with the mucosa facing up. A shallow,
longitudinal cut was made to remove mucosa from the underlying myenteric
plexus and smooth muscle. Mucosa was then carefully teased away, starting
from the cut and moving proximally along the colon. Upon isolation of the
myenteric plexus and longitudinal smooth muscle, tissues were placed in 10%
neutral-buffered formalin for 2 hours at RT. Following fixation, tissue was placed
in 30% sucrose solution dissolved in PBS and stored at 4oC until further
processing. The day of immunostaining, tissue was removed from sucrose
solution and washed 3x with PBS for a period of 1 hour to rehydrate the tissue.
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Tissue was then incubated with 1% Triton-X100 PBS for a period of 4 hours to
fully permeabilize the membranes. Samples were then washed with PBS 3x for
10 minutes and placed in 5% goat serum to block for 2 hours. Following blocking,
tissue was placed in the different primary antibodies (KV7.2 1:100, KV7.3 1:100,
Alomone Labs, Jerusaleum, Israel, ChAT 1:100 Millipore, Burlington, MA ) diluted
in blocking solution overnight at 4oC with gentle shaking. In the morning, tissue
was washed with PBS at RT 5x for 5 minutes. Upon completion of washing,
tissue was incubated with secondary antibody (anti-rabbit Alexa Fluor 488 1:500,
anti-goat Alexa Fluor 546 1:500) for 4 hours in the dark at RT. Tissue was
removed and washed with PBS 5x for 5 mins to dilute out any residual secondary
antibody. Samples were then mounted on slides with mounting media (Slowfade
Diamond, ThermoFisher, Waltham, MA) and imaged for immunolocalization
accordingly. All images were captured on LSM 510 confocal microscope (Carl
Zeiss, Oberkochen, Germany) with a 63x oil-immersion objective.

Percent Inhibition and Dose-Response.
Percent inhibition. The percent inhibition of the different drugs was calculated by
obtaining the maximal response from all applied agents and then dividing the
measured change in ISC by the maximal response to obtain a percent value. Data
was transformed into a percent due to variability in baseline measurements
between mounted tissues. Percent inhibition was calculated as follows:

Maximal response: Xbaseline Isc-Yremaining Isc
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Percent Inhibition: (XIsc prior to drug application-Ysteady-state Isc after drug application)
Maximal response
Dose-Response. This was performed to calculate a half-maximal inhibitory
concentration (IC50) for flupirtine (general Kv7 agonist) and ICA 110381 (specific
agonist of Kv7.2/3). Pharmacological agents were diluted from their respective
stock concentrations to a range of 10-4 M to 10-1 M, which were then diluted
1:1000 (5 µL into 5 mL) within the chamber. Different concentrations were added
sequentially, starting with 10-4 M and increasing by a factor of 10 for each
addition. Tissue was allowed to reach a steady-state prior to the application of
the next administered dose.

Statistics. All presented data represent mean ± standard error (sem) from five
different animals, unless otherwise denoted within the text. Statistical tests that
were performed on the presented data was student’s unpaired t-test using
Graphpad Prism 5.0 (San Diego, CA). p < 0.001 was used for the determination
of significance.

Stock solutions. Indomethacin was prepared as a 5 mM stock solution in
ethanol. Ussing chamber stocks are as follows: 1 mM tetrodotoxin (TTX,
dissolved in acetic acid, Tocris Pharmaceuticals, Minneapolis, MN), 10 mM
tolterodine (TOL, dissolved in H2O, Tocris Pharmaceuticals, Minneapolis, MN),
50 mM flupirtine (FLU, dissolved in DMSO, Tocris Pharmaceuticals, Minneapolis,
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MN), 50 mM ICA 110381 (ICA, dissolved in DMSO, Tocris Pharmaceuticals,
Minneapolis,

MN),

50

mM

nicotine

(NICO,

dissolved

in

H2O,

Tocris

Pharmaceuticals, Minneapolis, MN), 10 mM forskolin (FSK, dissolved in DMSO,
Tocris Pharmaceuticals, Minneapolis, MN), and 50 mM XE-991 (dissolved in
H2O, Tocris Pharmaceuticals, Minneapolis, MN).

Results
Inhibition of ISC in Whole-Mount Colon with the Kv7 Activator Flupirtine.
Previous studies have shown that inhibition of the ENS with tetrodotoxin (TTX), a
voltage-sensitive Na+ channel (NaV) inhibitor, was able to significantly attenuate
the on-going basal Cl- secretion in Ussing chambers [25]. This is accomplished
via inhibiting propagation of action potentials and eventual release of
neurotransmitters [26]. With this in mind, flupirtine, a Kv7 activator that
hyperpolarizes neurons and ultimately decreases release of neurotransmitter,
could be applied to indirectly inhibit on-going Cl- secretion. As demonstrated by
the representative trace (Fig. 1A), basolateral 100 µM flupirtine application was
able to significantly decrease the observed ISC from the mounted tissue.
However, basolateral application of 1 µM TTX only slightly decreased ISC (Fig.
1A). Group data of 100 µM flupirtine application prior to 1 µM TTX administration
demonstrated a similar pattern of flupirtine being responsible for a significant
majority of the percent of inhibited ISC (FLU vs. TTX, 94.23 ± 1.50 % vs. 5.77 ±
1.50 %) (Fig. 1C). However, administration of 1 µM TTX prior to flupirtine resulted
in a significant decrease in measured ISC, while flupirtine only slightly decreased
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ISC (Fig. 1B). Group data of TTX administration prior to flupirtine also
demonstrated a similar pattern with TTX conferring a majority of the percentinhibited ISC in Ussing chamber experiments (TTX vs. FLU, 77.92 ± 6.6 % vs.
22.08 ± 6.6 %, p< 0.001) (Fig.1D). Comparison of order of administration
demonstrated flupirtine following TTX application was significantly less than
when administered prior to TTX (22.08 ± 6.58 % vs. 94.23 ± 1.50 %, Fig. 1E).

Dose-Response of ISC to Basolateral Flupirtine Application. Following the
initial finding of flupirtine decreasing ISC in colonic epithelium, we decided to more
fully characterize the drug by determining a half-maximal inhibitory concentration
(IC50). Initial administration of 100 nM flupirtine was unable to elicit any effect on
the tissue, as demonstrated by the representative trace (Fig. 2A). However,
increasing doses of flupirtine, from 1 µM up to highest concentration of 100 µM,
were able to inhibit the on-going ISC (Fig. 2A). The data as a whole demonstrated
a significant inhibition with the addition of 10 µM flupirtine, which accounted for a
49.44 ± 5.9 % decrease from the previous baseline current. 100 µM flupirtine
application was also able to further decrease ISC (37.48 ± 3.8 %), however not as
robustly as the previously administered 10 µM dose, which would indicate
reaching an asymptote of effect

(Fig. 2B). Utilizing a non-linear fit to the

calculated percent of inhibition presented in Fig. 2B, we were able to calculate an
IC50 for flupirtine of 9.37 ± 0.42 µM.
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Inhibition of on-going ISC in Colonic Epithelium with the Muscarinic
Antagonist Tolterodine. As described previously, NaV channels are located
within ENS neurons, so inhibition of those channels with TTX would inhibit
neurotransmitter release (i.e. acetylcholine) onto epithelial cells. To further
establish that basolateral flupirtine may be acting on ENS neurons, we decided to
use the muscarinic antagonist tolterodine to inhibit acetylcholine activation of
muscarinic receptors on epithelial cells. As expected and in concordance with
literature [27], basolateral application of 10 µM tolterodine was able to inhibit a
significant amount of basal ISC (80.35 ± 3.72 %, Fig. 3C), as illustrated by the
representative trace (Fig. 3A). Addition of 100 µM flupirtine was able to further
decrease ISC (19.65 ± 3.72 %, Fig. 3A/C). However, the addition of 100 µM
flupirtine prior to 10 µM tolterodine application demonstrated a significant
inhibition of ISC (99.59 ± 0.41 %, Fig. 3B/D), more similar to flupirtine
administration prior to 1 µM TTX (Fig. 1D). Unexpectedly though, addition of 10
µM tolterodine to the basolateral surface led to a paradoxical increase in ISC
(-15.2 ± 8.56 % Fig. 3B/D), as opposed to the decrease in ISC observed with
flupirtine application. Comparison of order of administration demonstrated that
flupirtine administration prior to tolterodine resulted in a significant increase in
percent of inhibition (99.59 ± 0.41 % vs. 19.65 ± 3.72 %, Fig. 3E).

Pre-Incubation with Flupirtine Inhibits Basolaterally-Administered NicotineInduced ISC. Increased firing of ENS neurons has previously been shown to elicit
increases in measured ISC [4]. In line with this notion, we decided to activate ENS

89

neurons via basolateral addition of 100 µM nicotine. As illustrated by the
representative trace (Fig. 4A), basolateral administration of nicotine dramatically
increased measured ISC. Tissue that was pre-incubated with 100 µM flupirtine did
exhibit the expected decrease in ISC. However, addition of 100 µM nicotine was
not able to stimulate ISC (Fig. 4B). Tissues that received nicotine-only were able
to elicit large increases in ISC, while tissues that were pre-incubated with flupirtine
were practically unresponsive to nicotine (93.22 ± 18.86 µA/cm2 vs. 0.26 ± 1.12
µA/cm2, Fig. 4C).

Application of Flupirtine and TTX in T84 Monolayers Does Not Inhibit ISC.
T84 monolayers have been used to study the colonic epithelium for several
decades [28, 29]. The T84 cell line was originally isolated from a colonic
adenocarcinoma, and consists of a homogenous population of secretory
epithelium [30]. Therefore, application of any pharmacological agents that
interact with ENS neurons to exert their effect would not demonstrate an efficacy
in the T84 cell line. To establish this within our lab, we first mounted T84
monolayers in the Ussing chamber, and upon reaching a steady-state applied 1
µM TTX to the basolateral surface of the monolayer. TTX was without effect (Fig.
5A/C), however to confirm that monolayers were functioning as a tight epithelium
10 µM forskolin (FSK) was applied basolaterally. As expected, 10 µM FSK was
able to increase ISC dramatically (24.58 ± 2.88 µA/cm2, Fig. 5A/D). Following this
outcome, another group of monolayers were administered 100 µM flupirtine to
the basolateral side of the chamber. As previously seen with TTX application,
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100 µM flupirtine was unable to decrease measured ISC, however, there was a
very modest increase in baseline ISC (0.57 ± 0.23 µA/cm2, Fig. 5B/C). T84
monolayers were once again administered 10 µM FSK, which significantly
increased ISC (24.61 ± 4.21 µA/cm2) to comparable levels of T84 monolayers
exposed to TTX (Fig. 5D). Both groups were then exposed to 50 µM XE-991
(Kv7 antagonist), which demonstrated a significant inhibition of of FSK-stimulated
ISC (Fig. 5A/B)

Kv7.2 and KV7.3 Exhibit Co-Localization with Choline Acetyl Transferase in
ENS Neurons. Since previous work has shown that KV7.2/3 are crucial to the
native M current in neurons and may contribute to the observed effect of flupirtine
on ISC, we decided to immuno-label for the two different channels in whole mount
tissue. Choline acetyl transferase (ChAT) was used as a marker of enteric
neurons due to the high abundance of cholinergic neurons in the ENS, and
potential co-localization of the ion channels of interest.

ChAT consistently

labeled axons of enteric neurons, as illustrated by Fig. 6A/D. KV7.2 and KV7.3
(Fig. 6B/E) consistently co-localized with enteric neuronal axons that were
positively immuno-stained for ChAT (Fig. 6C/F).

ICA 110381, a Specific Activator of KV7.2/3, Inhibits ISC in a Dose-Dependent
Manner. Following identification of KV7.2 and KV7.3 in ENS neurons, we decided
to use a specific activator of the heterotetramer, KV7.2/3. ICA 110381 has
previously demonstrated selectivity for KV7.2/3 over the other members of the
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KCNQ family of K+ channels [31]. Basolateral application of 100 µM ICA was able
to significantly inhibit the ISC (Fig. 7A). Similar to before with flupirtine,
administration of 1 µM TTX following ICA was practically unable to decrease ISC
(Fig. 7A). ICA 110381 was able to account for 96.88 ± 0.94 % of the total
inhibited ISC, while 1 µM TTX only inhibited 3.12 ± 0.94 % of the current (Fig. 7B).
A dose-response curve was also generated for ICA 110381 (Fig. 7C).
Concentrations ranging from 1 µM to 100 µM were able to decrease ISC. The use
of a non-linear fit of the grouped data allowed for the calculation of an IC50 for
ICA 110381, which was 10.55 ± 0.75 µM (Fig. 7D).

Discussion
Our findings in this study indicate that hyperpolarization of enteric neurons
with the KV7 activator flupirtine is able to decrease resultant mucosal secretion
via decreased neuronal firing. This conclusion is evidenced by the fact that
flupirtine administration prior to TTX leads to substantial inhibition of baseline ISC,
however the simple reversal of that order leads to a significant inhibition of ISC by
TTX with a much smaller contribution from flupirtine (Fig. 1). As not to rely on this
as our only evidence, we then characterized the ability of flupirtine to inhibit
nicotine-stimulated ISC, which is mediated through nicotinic receptors on postganglionic

fibers

[32].

Control

tissue

administered

basolateral

nicotine

demonstrated a significant increase in ISC, however pre-incubation with flupirtine
left the tissue practically unresponsive, owing to ENS neurons being substantially
hyperpolarized (Fig. 4). Also, to more fully implicate the ENS in mediating the
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effects of flupirtine, T84 monolayers [30] did not exhibit a decrease in ISC upon
basolateral administration (Fig. 5). We then wanted to try and characterize the
specific KV7 channels responsible for mediating the effects of flupirtine.
Immunofluorescence studies demonstrated that the canonical M current
channels, KV7.2 and KV7.3, co-localized with axons that stained positively for
ChAT (Fig. 6). Finally, the use of the KV7.2/3 activator, ICA 110381,
demonstrated a similar profile to flupirtine administration (Fig. 7). In total, our
results would indicate that the decrease in ISC from basolateral application of
flupirtine is ENS-mediated via hyperpolarization of enteric neurons through
activation of KV7.2/3.
KV7.1, another member of the KV7 family, has been localized and
functionally described in epithelial tissues [33-35] and could be thought to
participate in the observed response in native tissue. However, activation of
KV7.1 in epithelial tissues leads to an increase in K+ recycling via the basolateral
membrane and an increase in apical Cl- secretion [36]. These previous
observations would agree with our results that flupirtine was not able to decrease
ISC in T84 monolayers, but actually resulted in a small increase in ISC [37] from
activation of presumably of KV7.1 (Fig. 5). To further demonstrate the importance
of KV7 in apical Cl- secretion, XE-991, a non-specific KV7 inhibitor, was
administered

to

the

basolateral

membrane

of

T84

monolayers,

which

demonstrated a significant decrease in FSK-mediated ISC.
The effect of flupirtine on cholinergic neurons was also studied, since
cholinergic fibers make up approximately 60% of neurons within the ENS [38]. As
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expected, tolterodine (muscarinic receptor antagonist) application was able to
partially inhibit on-going mucosal Cl- secretion [39, 40]. Flupirtine was able to
further decrease measured ISC. This would indicate that non-cholinergic
neurotransmitters also participate in modulating mucosal electrolyte transport,
which has also been previously described [25]. Application of flupirtine prior to
tolterodine would then be expected to inhibit all ENS neurons, and the application
of the muscarinic receptor antagonist following this would have no effect or only
very modestly decrease ISC. However, tolterodine application following flupirtine
administration unexpectedly increased ISC (Fig. 3B/D). This could be the result of
a subpopulation of interneurons that are less sensitive to flupirtine. Application of
tolterodine would block the remaining excitatory stimulation on inhibitory
secretomotor neurons, which would remove the “brake”, and lead to the
observed increase in ISC.
Previous studies have shown that several gastrointestinal disorders result
in an overall increase in excitability of ENS neurons [8-10, 41]. However, current
clinical options are limited for these pathologies, with many observed adverse
effects [42, 43]. Unfortunately, flupirtine, which had been available for nearly
three decades in several European countries, was recently removed from the
market due to issues of hepatotoxicity [44]. Development of novel KV7 channel
activators, with a greater safety profile, could yield therapeutic potential in
patients that have been unresponsive to traditional treatments for an over-active
ENS. Since KV7 channel activation causes a sustained hyperpolarization of
enteric neurons that synapse on the epithelium, as well as the smooth muscle,
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targeted treatment could help to alleviate associated-symptoms. Also, our
immunofluorescence studies demonstrate localization of KV7.3 in gastrointestinal
smooth muscle (Fig. 6), which along with previous observations of KV7 channels
in smooth muscle may further enhance the efficacy of a KV7 activator by reducing
motility of gastrointestinal tract [45]. In all, KV7 activators could potentially be
utilized clinically for the treatment of gastrointestinal disorders attributed to hyperexcitability of the ENS.
In summary, our results demonstrate that activation of KV7 channels via
flupirtine in enteric neurons significantly inhibits mucosal electrolyte transport in
the colon. As demonstrated through immunofluorescence studies and a specific
pharmacological activator, this mechanism is mediated through KV7.2/3 located
within axons of enteric neurons. Also, this discovery may have clinical
significance as a potential therapeutic agent to decrease ENS hyper-excitability
in certain gastrointestinal pathologies and associated-outcomes.
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Figure Legends
Figure 1. Basolateral 100 µM Flupirtine Inhibits ISC in the Murine Distal
Colon. A. Representative trace of basolateral application of 1 µM tetrodotoxin
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(TTX) on full thickness tissue preparation in the Ussing chamber. TTX was able
to decrease ISC, however addition of basolateral 100 µM flupirtine (Flu) following
the TTX-induced plateau only modestly decreased ISC. B. Representative trace of
basolateral application of 100 µM Flu in the Ussing chamber. Measured ISC
substantially decreased from the previous baseline, however application of 1 µM
TTX only slightly decreased measured ISC. C. Group data of percent inhibition of
maximal response of 1 µM TTX prior to 100 µM Flu. D. Group data of percent
inhibition of maximal response of 100 µM Flu prior to 1 µM TTX application. E.
Group data of percent inhibition of maximal response of 100 µM Flu prior to or
following TTX application. All presented bar graphs are summarized data of
means ± SE from five different animals (n=5). Plotted points on each bar graph
are representative of individual experiments. *p < 0.001 – compared to control.

Figure 2. Dose-Response of Basolateral application of Flupirtine in Murine
Distal Colon. A. Representative trace of a dose-response curve of Flu. The
initial administered concentration of Flu was 100 nM and increased sequentially
by a log order of 10 until reaching a final concentration of 100 µM Flu. Each
arrow within the trace indicates time of administration of an individual dose of Flu.
B. A dose-response curve of percent inhibition of maximal response was
generated from multiple experiments (n=5) to determine an approximate halfmaximal inhibitory concentration (IC50) in the murine distal colon.
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Figure 3. Tolterodine and Flupirtine Inhibit Cholinergic-induced ISC in the
Distal Colon. A. Representative trace of basolateral application of 10 µM
tolterodine (TOL) followed by basolateral 100 µM Flu on whole-mount distal colon
in the Ussing chamber. B. Representative trace of basolateral application of 100
µM Flu followed by 10 µM TOL in the Ussing chamber. C. Group data of percent
inhibition of maximal response of 10 µM TOL prior to Flu application. D. Group
data of percent inhibition of maximal response of 100 µM Flu prior to application
10 µM TOL. E. Group data of percent inhibition of maximal response of 100 µM
Flu prior to or following 10 µM TOL application. All presented bar graphs
represent summarized data of means ± SE from five different animals (n=5).
Plotted points on each bar graph represent individual experiments that contribute
to the overall mean and SE. *p < 0.001

Figure 4. Flupirtine Inhibits Nicotine-Induced Increases in ISC.
A. Representative trace of basolateral 100 µM nicotine (NICO)-induced
increases in measured ISC in the distal colon. B. Representative trace of 100 µM
NICO-induced increases in ISC that was pre-incubated with 100 µM Flu. C. Group
data of NICO-induced ΔISC in tissue that was pre-incubated with or without 100
µM Flu prior to basolateral 100 µM NICO administration. All presented bar
graphs represent summarized data of means ± SE from five different animals
(n=5). Plotted points on each bar graph represent individual experiments that
contribute to the overall mean and SE. *p < 0.001
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Figure 5. Flupirtine Does Not Decrease Isc in T84 Monolayers. A.
Representative trace of measured ISC in T84 monolayers that were treated with
basolateral 100 µM Flu. Monolayers were then stimulated with 10 µM forskolin
(FSK) that was inhibited with 50 µM XE-991 upon reaching a steady-state. B.
Representative trace of measured ISC in T84 monolayers that were incubated with
1 µM TTX. Monolayers were then stimulated with 10 µM FSK and then inhibited
with 50 µM XE-991. C. Group data of measured ΔISC following either 100 µM Flu
or 1 µM TTX. D. Group data of 10 µM FSK-induced ΔISC from T84 monolayers
incubated with Flu or TTX. All presented bar graphs represent summarized data
of means ± SE from five different animals (n=5). Plotted points on each bar graph
represent individual experiments that contribute to the overall mean and SE. *p <
0.001

Figure 6. Kv7.2 and KV7.3 Co-Localize with Choline Acetyl Transferase in
Enteric Neurons of the Murine Distal Colon. A/D. Axons of enteric neurons
that stained positive for choline acetyl transferase (ChAT). B/E. Positive immunostaining for KV7.2 and KV7.3 in murine distal colon. C/F. Merged images of
panels A/B and D/E demonstrate co-localization of KV7.2 and KV7.3 with axons
positively-stained for ChAT.

Figure 7. The Specific KV7.2/3 Activator, ICA 110381, Inhibits ISC in the
Murine Distal Colon. A. Representative trace of measured ISC that has been
administered 100 µM ICA 110381(ICA) to the basolateral surface. This was then

104

followed by 1 µM TTX application, which was also applied to the basolateral
surface. B. Group data of percent inhibition of maximal response of tissues that
received basolateral 100 µM ICA prior to 1 µM TTX. C. Representative trace of a
dose-response curve that was sequentially administered 100 nM ICA, increasing
by a factor of ten each time, with a final basolateral concentration of 100 µM ICA.
Each arrow indicates the time of administration of each corresponding
concentration of ICA. D. A dose-response of percent inhibition of maximal
response from multiple experiments (n=5) was generated to determine the IC50 of
ICA. All presented bar graphs represent summarized data of means ± SE from
five different animals (n=5). Plotted points on each bar graph represent individual
experiments that contribute to the overall mean and SE.
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Chapter IV

Conclusions and Proposal of Future Work
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As previously presented, I have demonstrated that the absence of Ca2+activated Cl- secretion in DSS-treated animals is a result of decreased
expression of TMEM16A in colonic epithelium. I have also shown that activation
of KCNQ2/3 and the resultant hyperpolarization in enteric neurons can inhibit
mucosal Cl- secretion. Each of these are novel findings and contribute to their
respective fields. The following discussion will elaborate on their greater
implications with a specific focus on inflammatory bowel disease.
TMEM16A and Dextran-Sulfate Sodium-Induced Colitis
As previously discussed, the DSS-induced colitis is a commonly utilized
animal model of inflammatory bowel disease (IBD) [1]. It has previously been
shown that the colitis that develops significantly blunts apical Cl- secretion in the
distal colon [2]. More specifically though, agonists that elicit increases in
intracellular Ca2+ and resultant Cl- secretion have been shown to be completely
abolished. Stimulation with agonists that normally increase ISC actually lead to a
decrease following DSS treatment. Previous studies that focused on this
phenomenon attributed these changes to a dysfunctioning ENS or alterations in
the basolateral K+ conductance [3, 4]. However, these studies were prior to the
identification of TMEM16A, a CaCC. Our group was the first to reexamine this
previously observed effect of DSS-induced colitis, and we were able to determine
that TMEM16A was in fact down-regulated in the DSS-induced colitis model. Our
functional data demonstrated that CCH-induced Cl- secretion in DSS animals
was not only abolished, but it had reversed in its direction of polarity, similar to
previous reports. Also, the use of a Ca2+ ionophore (ionomycin) was able to
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reproduce a similar ISC profile to that of CCH, indicating this mechanism is
mediated via Ca2+. However, most important of all the findings was the
quantification of TMEM16A via immunoblot. Immunoblot analysis demonstrated a
significant

reduction

in

total

TMEM16A

in

colonic

epithelium.

Immunohistochemistry also demonstrated that the remaining protein was not
properly trafficked to the cellular membrane in colonic epithelium.
While this seems to answer the question as to why Ca2+-activated Clsecretion is absent in DSS-exposed animals, it does not solve the entire riddle.
The mechanism by which TMEM16A is down-regulated in colonic epithelium
following DSS-exposure is still unknown. However, several groups have
previously demonstrated that Ca2+-activated Cl- secretion could be decreased
following incubation with certain cytokines in immortalized cell lines of colonic
epithelium [5, 6]. Both cytokines (IL-4 and TGF-β) that decreased Ca2+-activated
Cl- secretion are more typically represented in a Th2-mediated immune response.
Since, the utilization of the Balb/c mice in our study typically respond in more of a
Th2 response (and our qPCR results would indicate as such), this may be the
reason for loss of TMEM16A protein expression. With this as our working
hypothesis, it would be interesting to repeat this study in C57Bl/6 mice, which
typically demonstrate a Th1 response upon DSS exposure, and determine if they
would demonstrate a protection against loss of TMEM16A. Also, colon specificknockout of TGF-β or IL-4 in combination with DSS-induction could potentially
provide some protective mechanism by preventing signaling through either
cellular pathway.
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While signaling through a Th2 immune response may be a likely cause for
down-regulation of TMEM16A, the most important question to answer is, ‘Does
down-regulation of TMEM16A have any role in the development of or
continuance of inflammation in DSS-colitis, or for that matter IBD?”. The
evidence for this is much less than is present to even support the previously
proposed mechanism whereby TMEM16A is down-regulated in colonic
epithelium. However, it has been shown previously that Ca2+-activated Clsecretion decreases in the first couple days of DSS-exposure even though
physical symptoms such as loose stools with copious amounts of mucus do not
manifest until about day 5 of a one week exposure [1]. Also, animals treated with
DSS have disrupted mucus barriers that typically prevent interaction between the
host and the microbiome [7]. It has been demonstrated that activation of
TMEM16A is crucial for release of Muc5AC, however that study was conducted
in human bronchial epithelial cells [8]. Muc5AC and similar proteins like it are
necessary for maintaining the mucosal mucus barrier. Applying this knowledge, it
is plausible that down-regulation of TMEM16A in DSS-colitis or potentially IBD
could cause a decrease in Muc2 protein (more common in the intestine)
secretion and overall disruption in the mucus barrier lining the colonic lumen.
This would eventually lead to increased interaction between the microbiome and
the host, which would elicit an inflammatory response. While this is highly
speculative, it does provide a plausible route of further investigation.
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KCNQ2/3 and the Enteric Nervous System
The ENS has a vast supply of neurons along the entire gastrointestinal
tract. Previous research has demonstrated that the ENS can control local blood
flow, motility of the tract, and influence electrolyte transport [9]. As far as ENS
control over electrolyte transport, previous studies have demonstrated that
application of TTX (NaV inhibitor) or atropine (muscarinic antagonist) inhibits ongoing Cl- secretion via inhibition of ISC [10, 11]. Our study was similar in setup,
however, we focused on KCNQ channels and their contribution to resting
membrane potential in enteric neurons. Activation of KCNQ channels with
basolateral flupirtine was able to inhibit the observed ISC in full thickness tissue
from murine distal colon. This was achieved via inhibition of neurotransmitter
release from enteric neurons that were substantially hyperpolarized. Application
of TTX following flupirtine was practically unable to decrease the measured ISC.
Also, pre-incubation with flupirtine prior to stimulation with nicotine resulted in an
unresponsiveness of the tissue. Application of flupirtine on the T84 colonic
epithelial cell line further implicated that effect was mediated through the ENS,
since the monolayers were unresponsive to the drug. However, flupirtine is a
non-specific

activator

of

KCNQ

channels,

therefore

the

use

of

immunofluorescence was employed to demonstrate the presence of KCNQ2 and
KCNQ3 in enteric neurons.
The previously mentioned work seems to indicate that activation of KCNQ
channels in enteric neurons can lead to inhibition of neurotransmitter release.
Unfortunately, functional evidence of the exact channels that contribute to the
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observed response is lacking. While the use of a specific activator of KCNQ2/3
was utilized in the study, channel activators are prone to selectivity issues. A
specific inhibitor to the channel would be of clear benefit to the study and future
research. However, the only available KCNQ inhibitors are linopiridine and XE991, which are both global KCNQ inhibitors. This means that a specific channel
can not be identified from inhibition with either of the drugs. Also, KCNQ1 has
been characterized to reside on the basolateral membrane of colonic epithelium
and inhibition causes decreased apical Cl- secretion due to loss of a favorable
electrochemical gradient [12, 13]. So, application of either of the inhibitors causes
a decrease in ISC, when one might expect an increase due to increased firing of
enteric neurons. Hopefully in the future better pharmacological tools (inhibitors)
can be developed that will allow for this functional characterization, or the
development of a conditional knock-out model with an enteric neuron promoter.

The Enteric Nervous System And Inflammatory Bowel Disease
While seemingly disconnected, the two previously presented studies have
a potential common thread of IBD. Research has primarily focused on the
immune response that is present within the tissue, as well as, the changes in
electrolyte transport across the epithelial layer. However, it has been shown that
inflammation is able to elicit a hyper-excitability of enteric neurons [14, 15]. It
would be of personal future interest to evaluate the effects of DSS administration
on the ENS from the standpoint of electrolyte transport and epithelial integrity. I
would be curious to see if oral administration of KCNQ activators is capable of
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attenuating the deleterious effects of DSS-colitis and for that matter IBD as a
whole. Also, utilization of animal models with dysfunctional enteric KCNQ
channels with DSS administration would be interesting to characterize the
severity of colitis as well as alterations in epithelial transport. Hopefully in the
near future, activators truly specific to KCNQ2/3 will become available and allow
for this evaluation.
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